-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 C+8VVZYz+Xm80929BG1I0OWgkObazPjSoeszBGb3OM9s/d3MedhH1R86VBJoBTGj
 LJSt66RfD4l0HWGrhK5Y7g==

<SEC-DOCUMENT>0001104659-06-026752.txt : 20060424
<SEC-HEADER>0001104659-06-026752.hdr.sgml : 20060424
<ACCEPTANCE-DATETIME>20060424084156
ACCESSION NUMBER:		0001104659-06-026752
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20060601
FILED AS OF DATE:		20060424
DATE AS OF CHANGE:		20060424
EFFECTIVENESS DATE:		20060424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ANIKA THERAPEUTICS INC
		CENTRAL INDEX KEY:			0000898437
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				043145961
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14027
		FILM NUMBER:		06774012

	BUSINESS ADDRESS:	
		STREET 1:		236 WEST CUMMINGS PARK
		CITY:			WOBURN
		STATE:			MA
		ZIP:			01801
		BUSINESS PHONE:		6179326616

	MAIL ADDRESS:	
		STREET 1:		236 WEST CUMMINGS PARK
		CITY:			WOBURN
		STATE:			MA
		ZIP:			01801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA RESEARCH INC
		DATE OF NAME CHANGE:	19930309
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>a06-10148_1def14a.htm
<DESCRIPTION>DEFINITIVE PROXY STATEMENT
<TEXT>
<html>

<head>







</head>

<body lang="EN-US">

<div>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION<br>
Washington, D.C. 20549</font></b></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="4" face="Times New Roman" style="font-size:14.0pt;">SCHEDULE
14A</font></b></p>

<p align="center" style="margin:0pt 0pt 10.0pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Proxy
Statement Pursuant to Section 14(a) of<br>
the Securities Exchange Act of 1934 (Amendment
No.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="100%" colspan="2" valign="top" style="padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt;"><font face="Times New Roman">Filed by
  the Registrant&nbsp;&nbsp;</font><font face="Wingdings">x</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="2" valign="top" style="padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p style="font-size:10.0pt;margin:4.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filed
  by a Party other than the Registrant&nbsp;&nbsp;</font><font face="Wingdings">o</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="2" valign="top" style="padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p style="margin:4.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check
  the appropriate box:</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.18%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>
  </td>
  <td width="95%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:95.82%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preliminary Proxy
  Statement</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.18%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>
  </td>
  <td width="95%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:95.82%;">
  <p style="margin:0pt 0pt .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Confidential, for Use of the
  Commission Only (as permitted by Rule 14a-6(e)(2))</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.18%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">x</font></p>
  </td>
  <td width="95%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:95.82%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Definitive Proxy
  Statement</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.18%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>
  </td>
  <td width="95%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:95.82%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Definitive Additional
  Materials</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.18%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>
  </td>
  <td width="95%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:95.82%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Soliciting Material
  Pursuant to &#167;240.14a-12</font></p>
  </td>
 </tr>
</table>

</div>

<p style="font-size:1.0pt;line-height:1.0pt;margin:0pt 0pt 11.0pt;"><font face="Times New Roman">&nbsp;</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="100%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p align="center" style="font-size:10.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">ANIKA THERAPEUTICS, INC.</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="3" valign="top" style="border:none;padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Name
  of Registrant as Specified In Its Charter)</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="3" valign="top" style="border:none;padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Name
  of Person(s) Filing Proxy Statement, if other than the Registrant)</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="3" valign="top" style="padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="3" valign="top" style="padding:0pt 0pt 0pt 0pt;width:100.0%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Payment of Filing Fee
  (Check the appropriate box):</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">x</font></p>
  </td>
  <td width="95%" colspan="2" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:95.66%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No fee required.</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>
  </td>
  <td width="95%" colspan="2" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:95.66%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fee computed on table
  below per Exchange Act Rules 14a-6(i)(1) and&nbsp;0-11.</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font></p>
  </td>
  <td width="90%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title of each class of
  securities to which transaction applies:</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Aggregate number of
  securities to which transaction applies:</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Per unit price or
  other underlying value of transaction computed pursuant to Exchange Act Rule
  0-11 (set forth the amount on which the filing fee is calculated and state
  how it was determined):</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Proposed maximum
  aggregate value of transaction:</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total fee paid:</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>
  </td>
  <td width="95%" colspan="2" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:95.66%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fee paid previously
  with preliminary materials.</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>
  </td>
  <td width="95%" colspan="2" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:95.66%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check box if any part
  of the fee is offset as provided by Exchange Act Rule&nbsp;0-11(a)(2) and
  identify the filing for which the offsetting fee was paid previously.
  Identify the previous filing by registration statement number, or the Form or
  Schedule and the date of its filing.</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font></p>
  </td>
  <td width="90%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amount Previously
  Paid:</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form, Schedule or
  Registration Statement No.:</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filing Party:</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date Filed:</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="4%" valign="top" style="padding:0pt 0pt 0pt 0pt;width:4.34%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="bottom" style="padding:0pt 0pt 0pt 0pt;width:4.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="90%" valign="top" style="border:none;padding:0pt 0pt 0pt 0pt;width:90.72%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
</table>

</div>

<p style="font-size:1.0pt;line-height:1.0pt;margin:0pt 0pt 11.0pt;"><font face="Times New Roman">&nbsp;</font></p>

</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\fc\110115643800_D11085_1040460\10148-1-ba.htm',USER='jmsproofassembler',CD='Apr 20 11:57 2006' -->



<br clear="all" style="page-break-before:always;">

<div style="font-family:Times New Roman;">

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">ANIKA
THERAPEUTICS,&nbsp;INC.<a name="AnikaTherapeuticsinc__103123"></a><br>
<a name="AnikaTherapeuticsInc__103205"></a>160 NEW BOSTON STREET<a name="a160NewBostonStreet_103124"></a><br>
WOBURN, MASSACHUSETTS 01801<a name="WoburnMassachusetts01801_103124"></a></font></b></p>

<p style="font-style:italic;font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notice of Annual Meeting of Stockholders to<br>
be Held on Thursday, June&nbsp;1, 2006</font></i></b></p>

<p style="margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The 2006 Annual
Meeting of Stockholders of Anika Therapeutics,&nbsp;Inc., a Massachusetts
corporation, will be held at the offices of Goodwin Procter LLP, 53 State
Street, Boston, Massachusetts 02109 on Thursday, June&nbsp;1, 2006, at 10:00&nbsp;a.m.
local time for the following purposes:</font></p>

<p style="font-size:10.0pt;margin:0pt 0pt 6.0pt 40.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To elect two (2)&nbsp;Class&nbsp;I
directors, each to serve until the 2009 Annual Meeting of Stockholders and
until their respective successors are duly elected and qualified; and</p>

<p style="font-size:10.0pt;margin:0pt 0pt 6.0pt 40.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To consider and
act upon any other matters that may properly come before the Annual Meeting or
any adjournment or postponement thereof.</p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Any action may be taken on the foregoing proposals at
the Annual Meeting on the date specified above, or on any date or dates to
which the Annual Meeting may be adjourned or postponed.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Board of Directors has fixed the close of business
on April&nbsp;17, 2006 as the record date for determining the stockholders
entitled to receive notice of and to vote at the Annual Meeting and any
adjournments or postponements thereof. Only stockholders of record of our
common stock, par value $.01 per share, at the close of business on that date
will be entitled to notice of and to vote at the Annual Meeting and at any
adjournment or postponement thereof.</font></p>

<p style="margin:0pt 0pt 12.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You
are requested to fill in and sign the enclosed form of proxy, which is being
solicited by the Board of Directors, and to mail it promptly in the enclosed
postage prepaid envelope. <b><font style="font-weight:bold;">Regardless of the
number of shares you own, your vote is important</font></b>. Any proxy may be
revoked by delivery of a later dated proxy. Stockholders of record who attend
the Annual Meeting may vote in person, even if they have delivered a signed
proxy.</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;">
 <tr>
  <td width="300" valign="top" style="padding:0pt .7pt 0pt 0pt;width:225.0pt;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt;"></p>
  </td>
  <td width="309" valign="top" style="padding:0pt .7pt 0pt 0pt;width:231.4pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By Order of the Board of Directors,</font></p>
  </td>
 </tr>
 <tr>
  <td width="300" valign="top" style="padding:0pt .7pt 0pt 0pt;width:225.0pt;">
  <p style="margin:8.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="309" valign="top" style="padding:0pt .7pt 0pt 0pt;width:231.4pt;">
  <p style="margin:8.0pt 0pt .0001pt;"><font size="2" face="Times New Roman"><img width="192" height="32" src="g101481bci001.gif" alt="GRAPHIC"></font></p>
  </td>
 </tr>
 <tr>
  <td width="300" valign="top" style="padding:0pt .7pt 0pt 0pt;width:225.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="309" valign="top" style="padding:0pt .7pt 0pt 0pt;width:231.4pt;">
  <p style="margin:6.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Kevin W. Quinlan,<i><font style="font-style:italic;">&nbsp;</font>Secretary</i></font></p>
  </td>
 </tr>
 <tr>
  <td width="300" valign="top" style="padding:0pt .7pt 0pt 0pt;width:225.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Woburn,
  Massachusetts <br>
  April&nbsp;25, 2006</font></p>
  </td>
  <td width="309" valign="top" style="padding:0pt .7pt 0pt 0pt;width:231.4pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
</table>

</div>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHETHER OR NOT YOU EXPECT TO ATTEND THE MEETING,
PLEASE COMPLETE, DATE AND SIGN THE ENCLOSED PROXY AND MAIL IT PROMPTLY IN THE
ENCLOSED ENVELOPE IN ORDER TO ENSURE REPRESENTATION OF YOUR SHARES. NO POSTAGE
NEED BE AFFIXED IF THE PROXY IS MAILED IN THE UNITED STATES. IF YOU ATTEND THE
ANNUAL MEETING, YOU MAY&nbsp;VOTE IN PERSON IF YOU WISH, EVEN IF YOU HAVE
PREVIOUSLY RETURNED YOUR PROXY.</font></p>

</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\fc\11112146419_D11085_1043602\10148-1-bc.htm',USER='jmsproofassembler',CD='Apr 21 12:14 2006' -->



<br clear="all" style="page-break-before:always;">

<div style="font-family:Times New Roman;">

<p style="font-weight:bold;margin:0pt 0pt 2.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">ANIKA
THERAPEUTICS,&nbsp;INC.<a name="AnikaTherapeuticsinc__104220"></a><br>
160 NEW BOSTON STREET<a name="a160NewBostonStreet_104220"></a><br>
WOBURN, MASSACHUSETTS 01801<a name="WoburnMassachusetts01801_104220"></a></font></b></p>

<p style="font-style:italic;font-weight:bold;margin:0pt 0pt 2.0pt;page-break-after:avoid;text-align:center;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Proxy Statement for
the Annual Meeting of Stockholders<br>
To Be Held on Thursday, June&nbsp;1, 2006</font></i></b></p>

<p style="margin:0pt 0pt 2.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">T</font><font size="2" style="font-size:9.5pt;">his proxy statement is furnished in
connection with the solicitation of proxies by the Board of Directors of Anika
Therapeutics,&nbsp;Inc., a Massachusetts corporation, for use at the 2006
Annual Meeting of Stockholders to be held at the offices of Goodwin Procter
LLP, 53 State Street, Boston, Massachusetts 02109 on Thursday, June&nbsp;1, 2006,
at 10:00&nbsp;a.m. local time and at any adjournment or postponement
thereof.&#160; At the Annual Meeting, the
stockholders will be asked to consider and vote upon the following matters:</font></p>

<p style="margin:0pt 0pt 2.0pt 40.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.&#160;&#160;&#160;&#160; The election of two (2)&nbsp;Class&nbsp;I directors, each to
serve until the 2009 Annual Meeting of Stockholders and until their respective
successors are duly elected and qualified; and</font></p>

<p style="margin:0pt 0pt 2.0pt 40.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.&#160;&#160;&#160;&#160; Such other business as may properly come before the Annual
Meeting and any adjournments or postponements thereof.</font></p>

<p style="margin:0pt 0pt 2.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:9.5pt;">This proxy statement, the
accompanying notice of Annual Meeting, the form of proxy and Anika Therapeutics&#146;
Annual Report are first being sent to stockholders on or about April&nbsp;25,
2006. Our Annual Report, however, is not a part of the proxy solicitation
material. The Board of Directors has fixed the close of business on
April&nbsp;17, 2006 as the record date for the determination of stockholders
entitled to notice of and to vote at the Annual Meeting. Only stockholders of
record of our common stock, par value $.01 per share, at the close of business
on the record date will be entitled to notice of and to vote at the Annual
Meeting. As of the record date, there were 10,572,832 shares of Common Stock
outstanding and entitled to vote at the Annual Meeting. Holders of Common Stock
as of the close of business on the record date will be entitled to one vote per
share.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 2.0pt;text-indent:20.0pt;"><b><font size="2" face="Times New Roman" style="font-size:9.5pt;">All properly authorized proxies received and not
revoked prior to or at the Annual Meeting will be voted in accordance with the
stockholders&#146; instructions by the persons named as proxies. If no voting
instructions are specified, properly executed proxies will be voted &#147;FOR&#148; the
election of the nominees for director listed in this proxy statement. If other
matters are presented, proxies will be voted in accordance with the discretion
of the persons named as proxies. A stockholder may revoke a proxy at any time
before its exercise by delivery of written revocation or a subsequently dated
proxy to the Secretary of Anika Therapeutics or by voting in person at the
Annual Meeting. Attendance at the Annual Meeting will not in and of itself
constitute revocation of a proxy.</font></b></p>

<p style="margin:0pt 0pt 2.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:9.5pt;">The presence, in person or
by proxy, of holders of at least a majority of the total number of outstanding
shares of Common Stock entitled to vote is necessary to constitute a quorum for
the transaction of business at the Annual Meeting. Shares held of record by
stockholders or their nominees who do not return a signed and dated proxy or
attend the Annual Meeting in person will not be considered present or
represented at the Annual Meeting and will not be counted in determining the
presence of a quorum. Proxies withholding authority or marked as abstaining
from a particular matter will be treated as present for purposes of determining
whether a quorum is present for the Annual Meeting, but will not be counted as
voting on any proposal for which authority is withheld or an abstention is
indicated. If your Common Stock is held by a broker, bank or other nominee
(i.e., in &#147;street name&#148;) and you fail to give instructions as to how you want
your shares voted (a &#147;non-vote&#148;), the broker, bank or other nominee may
in certain circumstances, but is not required to, vote the shares in their own
discretion; however, in certain circumstances a broker will not be permitted to
vote such shares in its own discretion. Proxies returned by brokers as &#147;non-votes&#148;
on behalf of shares held in street name will be counted only for the purpose of
determining the presence or absence of a quorum for the transaction of
business. Any shares not voted (whether by abstention, broker non-vote or
otherwise) will have no impact on the proposal to approve the election of
directors except to the extent that the failure to vote for an individual in
the election of directors results in another individual receiving a larger
percentage of votes.</font></p>

<p style="margin:0pt 0pt 2.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:9.5pt;">The election of directors
will be determined by a plurality of the votes cast if a quorum is present. In
a plurality election, votes may only be cast in favor of or withheld from each
proposal; votes that are withheld will be excluded entirely from the vote and
will have no effect. This means that the two persons receiving the highest
number of &#147;FOR&#148; votes will be elected as directors.</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">1</font></p>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='1',FILE='C:\fc\11112144319_D11085_1043602\10148-1-be.htm',USER='jmsproofassembler',CD='Apr 21 12:02 2006' -->



<br clear="all" style="page-break-before:always;">

<div>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">PROPOSAL 1<a name="Proposal1_104601"></a></font></b></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">ELECTION OF
DIRECTORS<a name="ElectionOfDirectors_104603"></a></font></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our Board of Directors is currently comprised of six
directors and is divided into three classes: Class&nbsp;I, Class&nbsp;II and Class&nbsp;III.
Each class of directors serves for a three-year term with one class of
directors being elected by our stockholders at each annual meeting.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Drs.&nbsp;Bower and Davidson serve as Class&nbsp;I
Directors with a term of office expiring at the 2006 Annual Meeting. Mr.&nbsp;Land
and Dr.&nbsp;Sadow serve as Class&nbsp;II Directors with a term of office
expiring at the 2007 Annual Meeting. Mr.&nbsp;Wheeler and Dr.&nbsp;Sherwood
serve as Class&nbsp;III Directors with a term of office expiring at the 2008
Annual Meeting.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Drs.&nbsp;Bower and Davidson are our Board of
Directors&#146; nominees for election to the Board of Directors at the Annual
Meeting. The Class&nbsp;I Directors will be elected to hold office until the
2009 Annual Meeting and until their successors are duly elected and qualified.
Unless otherwise instructed, the persons named in the accompanying proxy will
vote, as permitted by the Amended and Restated By-laws of Anika
Therapeutics, to elect Drs.&nbsp;Bower and Davidson as Class&nbsp;I Directors.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The election of a director requires the affirmative
vote of a plurality of votes cast by the holders of Common Stock entitled to
vote on the matter. In a plurality election, votes may only be cast in favor of
or withheld from each proposal; votes that are withheld will be excluded
entirely from the vote and will have no effect. This means that the two persons
receiving the highest number of &#147;FOR&#148; votes will be elected as directors.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If any of the Class&nbsp;I Directors become
unavailable or declines to serve, the persons acting under the accompanying
proxy may vote the proxy for the election of a substitute in their discretion.
The Board of Directors has no reason to believe that either of the nominees
will be unable or unwilling to serve if elected. There are no arrangements or
understandings between any nominee and any other person pursuant to which such
nominee was selected.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">THE BOARD OF
DIRECTORS RECOMMENDS A VOTE FOR EACH DIRECTOR NOMINEE.<a name="TheBoardOfDirectorsRecommendsAVot_104609"></a></font></b></p>

<p style="margin:0pt 0pt 12.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
following table sets forth the name of each director, including the nominees
for Class&nbsp;I Director, his age and the year in which he became a director
of Anika Therapeutics.</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;">
 <tr>
  <td width="70" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:52.7pt;">
  <p align="left" style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Director&nbsp;Name</font></b></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="325" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:243.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="25" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:18.7pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Age</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="41" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:30.45pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Director<br>
  Since</font></b></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="402" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:301.2pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Class&nbsp;I
  Directors:</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.45pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="402" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:301.2pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Joseph L. Bower</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">67</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.45pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1993</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="402" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:301.2pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Eugene A.
  Davidson, Ph.D.</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">75</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.45pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1993</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="402" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:301.2pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Class&nbsp;II
  Directors:</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.45pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="402" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:301.2pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Raymond J. Land</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">61</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.45pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2006</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="402" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:301.2pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Harvey S. Sadow,
  Ph.D.</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">83</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.45pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1995</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="402" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:301.2pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Class&nbsp;III
  Directors:</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.45pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="402" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:301.2pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Steven E. Wheeler</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">59</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.45pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1993</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="402" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:301.2pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Charles H. Sherwood,
  Ph.D.</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">59</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.6pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.45pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2002</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.5pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
</table>

</div>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr. Bower joined the Board of Directors of Anika
Therapeutics in February&nbsp;1993 and has served as Lead Director since April&nbsp;2005.
He has held various positions at the Harvard Business School since 1963, where
he was named Professor of Business Administration in 1972 and Donald Kirk David
Professor of Business Administration in 1986. He has served as Chairman of the
Doctoral Programs, Director of Research, Senior Associate Dean for External
Relations, Chair of the General Management Area and is currently Chair of the
General Manager Program. Dr.&nbsp;Bower received an A.B. from Harvard
University </font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">2</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='2',FILE='C:\fc\11112254538_D11085_1043602\10148-1-de.htm',USER='jmsproofassembler',CD='Apr 21 12:03 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 6.0pt;text-indent:0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">and an M.B.A. and a D.B.A.
from the Harvard Business School. He is a director of Brown Shoe Company,&nbsp;Inc.,
New America High Income Fund, Sonesta International Hotels Corporation, Loews
Corporation, and TH Lee Putnam EOP.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr. Davidson joined the Board of Directors of Anika
Therapeutics in February&nbsp;1993. He was the Chairman of the Department of
Biochemistry and Molecular Biology at Georgetown University Medical School from
April&nbsp;1988 until June&nbsp;30, 2003, and is currently a professor in that
department. Prior to this position, he was the Chairman of the Department of
Biological Chemistry at the Milton S. Hershey Medical Center of the Pennsylvania
State University from October&nbsp;1967 to April&nbsp;1988. Dr.&nbsp;Davidson
also served as Associate Dean for Education at the Milton S. Hershey Medical
Center from November&nbsp;1975 to January&nbsp;1987. Dr.&nbsp;Davidson received
a B.S. in Chemistry from the University of California, Los Angeles, and a Ph.D.
in Biochemistry from Columbia University.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr. Land joined the Board of Directors of Anika
Therapeutics in January&nbsp;2006. Mr.&nbsp;Land is currently Senior Vice
President and Chief Financial Officer of Orchid Cellmark Inc., which he joined
in June&nbsp;2005. Mr.&nbsp;Land has more than 30 years of experience in
financial and general management positions. From 1997 until May&nbsp;2005, Mr.&nbsp;Land
served as Chief Financial Officer of Nasdaq-traded Genecor International,&nbsp;Inc.,
a diversified biotechnology company focusing on bioproducts and healthcare.
Mr.&nbsp;Land also served as Senior Vice President and Chief Financial Officer
for Genecor from 1997 until its acquisition by the global company Danisco was
completed in April&nbsp;2005. From 1991 to 1996, he served as Senior Vice
President and Chief Financial Officer for publicly traded West Pharmaceutical
Services,&nbsp;Inc. Previously, Mr.&nbsp;Land was with Campbell Soup Company,&nbsp;Inc.
where for nine years he held increasingly senior financial positions and also served
as General Manager of a frozen food division. Prior to joining Campbell Soup,
he was with Coopers and Lybrand for nine years. Mr.&nbsp;Land is a Certified
Public Accountant and has a degree in accounting and finance from Temple
University.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr. Sadow joined the Board of Directors of Anika
Therapeutics in December&nbsp;1995. He was formerly Chairman of Cholestech
Corp. and a director of Rosetta Inpharmatics,&nbsp;Inc. and previously served
as Chairman of the Board of Directors of Trega Biosciences,&nbsp;Inc. From 1971
through 1992, Dr.&nbsp;Sadow served as President and Chief Executive Officer,
Director and later, Chairman of the Board of Boehringer Ingelheim Corporation.
He was also a member of the Board of Directors of the Pharmaceutical
Manufacturers Association, Chairman of the Pharmaceutical Manufacturers
Association Foundation and past president of the Connecticut Academy of Science
and Engineering. Dr.&nbsp;Sadow received a B.S. from the Virginia Military
Institute, an M.S. from the University of Kansas and a Ph.D. from the University
of Connecticut.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr. Wheeler joined the Board of Directors of Anika
Therapeutics in February&nbsp;1993. He is currently the President of Wheeler&nbsp;&amp;
Co., LLC, a private investment firm. He is also currently a director of
Bariston Partners, LLC, a private equity investment firm, PingTone,&nbsp;Inc.,
and The 81 Beacon Street Corporation. Between 1993 and February&nbsp;1996, he
was Managing Director and a director of Copley Real Estate Advisors and
President, Chief Executive Officer and a director of Copley Properties,&nbsp;Inc.,
a publicly traded real estate investment trust. He was the Chairman and Chief
Executive Officer of Hancock Realty Investors, which manages an equity real
estate portfolio, from 1991 to February&nbsp;1993. Prior to this position, he
was an Executive Vice President of Bank of New England Corporation from 1990 to
1991. Mr.&nbsp;Wheeler received a B.S. in Engineering from the University of
Virginia, an M.S. in Nuclear Engineering from the University of Michigan and an
M.B.A. from the Harvard Business School.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr. Sherwood was appointed
Chief Executive Officer of Anika Therapeutics in March&nbsp;2002. Dr.&nbsp;Sherwood
has served as President since June&nbsp;2001. Dr.&nbsp;Sherwood previously
served as Anika Therapeutics&#146; Chief Operating Officer beginning in June&nbsp;2001,
Vice President of Research and Development beginning in April&nbsp;2000 and
Vice President of Process Development and Engineering beginning in April&nbsp;1998.
He served as a consultant to Anika Therapeutics from January&nbsp;1998 to April&nbsp;1998.
</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">3</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='3',FILE='C:\fc\11112254538_D11085_1043602\10148-1-de.htm',USER='jmsproofassembler',CD='Apr 21 12:03 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 12.0pt;text-indent:0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">From
1995 to 1997, he was Senior Director of Medical Device Research and Development
for Chiron Vision. In April&nbsp;1995 Chiron Vision acquired IOLAB Corporation,
a division of Johnson&nbsp;&amp; Johnson where he had been Executive Director
of Research and Development from 1993 to 1995, Director of Materials Characterization
from 1989 to 1993 and Manager/Section&nbsp;Head from 1982 to 1989. Dr.&nbsp;Sherwood
was also a part-time faculty member in the Department of Chemistry at the
California State Polytechnic University, Pomona, California from 1984 to 1987. Dr.&nbsp;Sherwood
received a B.S. in Chemical Engineering from Cornell University, and a M.S. and
Ph.D. in Polymer Science and Engineering from the University of Massachusetts,
Amherst. Dr.&nbsp;Sherwood also received a Certificate in Management from
Claremont Graduate School.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">CORPORATE
GOVERNANCE AND BOARD OF DIRECTORS MATTERS<a name="CorporateGovernanceAndBoardOfDire_130227"></a></font></b></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Board of Directors
and Committees<a name="BoardOfDirectorsAndCommittees_104831"></a></font></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Anika Therapeutics&#146; Board of Directors is currently
comprised of six directors and is divided into three classes composed of two Class&nbsp;I
Directors (Drs.&nbsp;Bower and Davidson), two Class&nbsp;II Directors (Mr.&nbsp;Land
and Dr.&nbsp;Sadow) and two Class&nbsp;III Directors (Mr.&nbsp;Wheeler and Dr.&nbsp;Sherwood).
Each class of directors serves for a three-year term with one class of
directors being elected by our stockholders at each Annual Meeting. The Class&nbsp;I
Directors will be elected at the 2006 Annual Meeting with a term of office
expiring upon the election and qualification of directors at the 2009 Annual
Meeting. The terms of office of the Class&nbsp;II and Class&nbsp;III Directors
will expire upon the election and qualification of directors at the Annual
Meetings to be held in 2007 and 2008, respectively.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Board of Directors has determined that each of its
incumbent members, except for Dr.&nbsp;Sherwood, is &#147;independent&#148; within the
meaning of director independence standards of Rule&nbsp;4200(a)(15) of the
National Association of Securities Dealers, Nasdaq listing standards and the
Securities and Exchange Commission (&#147;SEC&#148;), including Rule&nbsp;10A-3(b)(1)&nbsp;under
the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;). The Board
based these determinations primarily on a review of the responses of each
director to questions regarding employment and compensation history,
affiliations and family and other relationships and on other relevant
discussions with the directors.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Independent directors meet periodically in executive
sessions without management participation. The executive sessions generally
occur in connection with regularly scheduled meetings of the Board of
Directors, committees of the Board of Directors and at other times the
independent directors deem appropriate. The executive sessions are chaired
either by the Lead Director or by the chair of the Board committee having
jurisdiction over the particular subject matter to be discussed at the
particular meeting or portion of a meeting.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Effective April&nbsp;11, 2005, the Board of Directors
designated Joseph Bower as Lead Director until his resignation or election of a
successor. The Lead Director&#146;s responsibilities are to convene and chair
meetings of the Board of Directors, convene and chair executive sessions of the
independent directors, provide feedback to the Chief Executive Officer on
executive sessions, collaborate with the Chief Executive Officer in setting
meeting agendas, and to facilitate discussion among the independent directors
outside of meetings of the Board. The Lead Director receives an annual retainer
of $10,000 (in addition to other director compensation) for service as the Lead
Director.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Anika Therapeutics&#146; Board of Directors met ten times
during 2005. No director attended less than 75% of the aggregate of: (1)&nbsp;the
total number of Board meetings and (2)&nbsp;the total number of meetings held
by all committees on which such director served. Our Annual Meeting of
Stockholders is generally held to coincide with one of the Board&#146;s regularly
scheduled meetings. Directors are strongly encouraged to attend the Annual
Meeting. Each of the then current directors attended the 2005 Annual Meeting of
Stockholders.</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">4</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='4',FILE='C:\fc\11112254538_D11085_1043602\10148-1-de.htm',USER='jmsproofassembler',CD='Apr 21 12:03 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 5.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Board of Directors currently has three standing committees:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 5.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>an
Audit Committee, the members of which are all independent for purposes of
Nasdaq listing standards and include: Mr.&nbsp;Land (Chairperson), Dr.&nbsp;Bower
and Mr.&nbsp;Wheeler;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 5.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>a
Compensation Committee, the members of which are all independent for purposes
of Nasdaq listing standards and include: Dr.&nbsp;Bower (Chairperson), Dr.&nbsp;Davidson
and Mr.&nbsp;Wheeler; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 5.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>a
Nominating Committee, the members of which are all independent for purposes of
Nasdaq listing standards and include: Mr.&nbsp;Wheeler (Chairperson), Dr.&nbsp;Bower,
Dr.&nbsp;Davidson, Mr.&nbsp;Land and Dr.&nbsp;Sadow.</p>

<p style="margin:0pt 0pt 5.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Board of Directors has
adopted a written charter for each of the Audit Committee, the Compensation
Committee and the Nominating Committee. The Audit Committee has adopted a Code
of Business Conduct and Ethics that applies to all of our employees, officers
and directors. You can find links to these materials in the corporate
governance section of our website at: <i><font style="font-style:italic;">http://www.anikatherapeutics.com</font></i>.
Please note that the information contained on the website is not incorporated
by reference in, or considered to be a part of, this proxy statement.</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 5.0pt;text-indent:20.0pt;"><font style="font-style:italic;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Audit Committee.</font></i></font><i><font style="font-style:italic;letter-spacing:-.1pt;">&nbsp;&nbsp; </font></i><font style="letter-spacing:-.1pt;">The current members of the Audit Committee are Mr.&nbsp;Land,
as Chairperson, Dr.&nbsp;Bower and Mr.&nbsp;Wheeler. </font>In January&nbsp;2006,
Samuel F. McKay resigned from the Board of Directors, and Mr.&nbsp;Land
replaced him on the Audit Committee. Messrs.&nbsp;McKay and Wheeler and Dr.&nbsp;Bower
served on the Audit Committee throughout 2005. The Board of Directors has
determined that each member of the Audit Committee meets the independence requirements
promulgated by Nasdaq and the SEC, including Rule&nbsp;10A-3(b)(1)&nbsp;under
the Exchange Act. In addition, the Board of Directors has determined that each
member of the Audit Committee is financially literate and has the requisite
financial sophistication&#160; <font style="letter-spacing:-.1pt;">required by the NASD audit committee requirements.
</font>In addition, the Board of Directors has determined that Mr.&nbsp;Land
qualifies as an &#147;audit committee financial expert&#148; under the rules&nbsp;of the
SEC. Stockholders should understand that this designation is a disclosure
requirement of the SEC related to Mr.&nbsp;Land&#146;s experience and understanding
with respect to certain accounting and auditing matters. The designation does
not impose upon Mr.&nbsp;Land any duties, obligations or liability that are
greater than are generally imposed on him as a member of the Audit Committee
and the Board of Directors, and his designation as an audit committee financial
expert pursuant to this SEC requirement does not affect the duties, obligations
or liability of any other member of the Audit Committee or the Board of
Directors.</p>

<p style="margin:0pt 0pt 5.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The purposes of the Audit
Committee are, among other things, to (1)&nbsp;oversee the accounting and
financial reporting processes of Anika Therapeutics and the audits of its
financial statements, (2)&nbsp;take or recommend that the Board of Directors
takes appropriate action to oversee the qualifications, independence and
performance of Anika Therapeutics&#146; independent registered public accounting
firm and (3)&nbsp;prepare an Audit Committee report as required by the SEC to
be included in Anika Therapeutics&#146; annual proxy statement. The Audit Committee
has direct authority to appoint, retain, oversee and, when appropriate,
terminate Anika Therapeutics&#146; independent registered public accounting firm.
The Audit Committee also has the responsibility to confer with the independent
registered public accounting firm regarding the scope, method and result of the
audit of our books and records and to report the same to the Board of Directors
and to establish and monitor a policy relative to non-audit services
provided by the independent registered public accounting firm in order to
ensure their independence.</font></p>

<p style="margin:0pt 0pt 5.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Audit Committee
operates under a written charter adopted by the Board of Directors, which was
revised effective March&nbsp;2004. The charter may be viewed in the corporate
governance section of Anika Therapeutics&#146; website at <i><font style="font-style:italic;">http://www.anikatherapeutics.com.</font></i> Please note that the
information contained on the website is not incorporated by reference in, or
considered to be a part of, this proxy statement. The Audit Committee holds
separate sessions of its meetings, outside the presence of management, with
Anika Therapeutics&#146; independent auditors in conjunction with each regularly
scheduled Audit Committee meeting that the independent auditors participate in.
The Audit Committee met six times during 2005.</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">5</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='5',FILE='C:\fc\11112254538_D11085_1043602\10148-1-de.htm',USER='jmsproofassembler',CD='Apr 21 12:03 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 5.0pt;text-indent:20.0pt;"><font style="font-style:italic;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Compensation Committee.</font></i></font><i><font style="font-style:italic;">&nbsp;&nbsp; </font></i>The current members of the
Compensation Committee are Dr.&nbsp;Bower, as Chairperson, Dr.&nbsp;Davidson
and Mr.&nbsp;Wheeler, each of whom is independent for purposes of Nasdaq listing
standards and the SEC. In January&nbsp;2006, Samuel F. McKay resigned from the
Board of Directors. Messrs.&nbsp;McKay and Wheeler and Drs.&nbsp;Bower and
Davidson served on the Compensation Committee throughout 2005. The Compensation
Committee, among other things, exercises on behalf of the Board of Directors
all of the Board&#146;s responsibilities relating to the development and
implementation of Anika Therapeutics&#146; compensation programs which provide
incentives that further Anika Therapeutics&#146; long-term strategic plan with
the goal of enhancing enduring stockholder value, including: (1)&nbsp;reviewing
and approving corporate goals and objectives relevant to the compensation of
Anika Therapeutics&#146; Chief Executive Officer and evaluating his or her
performance in light of those goals, (2)&nbsp;determining, with the advice and
assistance of the Chief Executive Officer, the compensation of Anika
Therapeutics&#146; officers other than the Chief Executive Officer, (3)&nbsp;overseeing
Anika Therapeutics&#146; overall compensation programs, including granting awards
under Anika Therapeutics&#146; 2003 Stock Option and Incentive Plan (the &#147;2003 Plan&#148;)
and, (4)&nbsp;preparing a report on executive compensation to be included in
Anika Therapeutics&#146; annual proxy statement. Until recently, the compensation
committee was also charged with annually reviewing and recommending to the
Board of Directors compensation for non-employee directors; those
responsibilities have been transferred to the Nominating Committee. The Board
of Directors has approved a written charter for the Compensation Committee, the
text of which may be viewed in the corporate governance section of Anika
Therapeutics&#146; website at <i><font style="font-style:italic;">http://www.anikatherapeutics.com.</font></i>
Please note that the information contained on the website is not incorporated
by reference in, or considered to be a part of, this proxy statement. The
Compensation Committee met eleven times during 2005.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 5.0pt;text-indent:20.0pt;"><font style="font-style:italic;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Nominating Committee.</font></i></font><i><font style="font-style:italic;">&nbsp;&nbsp; </font></i>The current members of the
Nominating Committee are Mr.&nbsp;Wheeler, as Chairperson, Dr.&nbsp;Bower, Dr.&nbsp;Davidson,
Mr.&nbsp;Land and Dr.&nbsp;Sadow, each of whom is independent for purposes of
Nasdaq listing standards and the SEC. In January&nbsp;2006, Samuel F. McKay
resigned from the Board of Directors and Mr.&nbsp;Land replaced him on the
Nominating Committee. Messrs.&nbsp;McKay and Wheeler and Drs.&nbsp;Bower,
Davidson and Sadow served on the Nominating Committee throughout 2005. The
Nominating Committee is primarily responsible for (1)&nbsp;recommending to the
Board of Directors the criteria for Board and committee membership and (2)&nbsp;identifying,
evaluating and recommending nominees to stand for election as directors at each
Annual Meeting of Stockholders, including incumbent directors and candidates
recommended by stockholders. In addition, the Nominating Committee was recently
given the responsibility of annually reviewing and recommending to the Board of
Directors compensation for non-employee directors. The Board of Directors
has approved a written charter for the Nominating Committee, the text of which
may be viewed in the corporate governance section of Anika Therapeutics&#146;
website at <i><font style="font-style:italic;">http://www.anikatherapeutics.com.</font></i>
Please note that the information contained on the website is not incorporated
by reference in, or considered to be a part of, this proxy statement. The
Nominating Committee met five times during 2005.</p>

<p style="margin:0pt 0pt 5.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">When considering
candidates for director, the Nominating Committee takes into account a number
of factors, including the following minimum qualifications: the nominee shall
have the highest personal and professional integrity, shall have demonstrated
exceptional ability and judgment, and shall be most effective, in conjunction
with the other members of the Board, in collectively serving the long-term
interests of the stockholders. In addition, the Nominating Committee will take
into consideration such other factors as it deems appropriate, including any
direct experience in the biotechnology, pharmaceutical and/or life sciences
industries or in the markets in which Anika Therapeutics operates and whether
the candidate, if elected, assists in achieving a mix of Board members that
represents a diversity of background and experience. The Nominating Committee
may also consider, among other things, the skills of the candidate, his or her
availability, depth and breadth of experience or other background
characteristics, and his or her independence. Depending upon the current needs
of the Board, these and other factors may be weighed more or less heavily by
the Nominating Committee.</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">6</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='6',FILE='C:\fc\11112254538_D11085_1043602\10148-1-de.htm',USER='jmsproofassembler',CD='Apr 21 12:03 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 5.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Nominating Committee
will consider written recommendations from stockholders of Anika Therapeutics
regarding potential candidates for election as directors. The Nominating
Committee will review and evaluate the qualifications of director nominee
candidates who have been recommended by stockholders in compliance with
procedures established from time to time by the Nominating Committee and
conduct such inquiries as it deems appropriate. The Nominating Committee will
consider for nomination any proposed director candidate who is deemed qualified
by the Nominating Committee in light of the minimum qualification and other
criteria for Board membership described above or otherwise approved by the
Board from time to time.</font></p>

<p style="margin:0pt 0pt 5.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stockholders
wishing to suggest a candidate for director should write to the Nominating
Committee c/o Chief Financial Officer at Anika Therapeutics,&nbsp;Inc., 160 New
Boston Street, Woburn, Massachusetts 01801 and include:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 5.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>The
name and address of record of the stockholder;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 5.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>A
representation that the stockholder is a record holder of Anika Therapeutics&#146;
Common Stock, or if the stockholder is not a record holder, evidence of
ownership in accordance with SEC Rule&nbsp;14a-8(b)(2)&nbsp;of the
Exchange Act;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 5.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>The
name, age, business and residential address, educational background, public
company directorships, current principal occupation or employment, and
principal occupation or employment for the preceding five (5)&nbsp;full fiscal
years of the proposed director candidate;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 5.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>A
description of the qualifications and background of the proposed director
candidate which addresses the minimum qualifications and other criteria for
Board membership approved by the Board from time to time;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 5.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>A
description of all arrangements or understandings between the stockholder and
the proposed director candidate;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 5.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>The
written consent of the proposed director candidate (1)&nbsp;to be named in the
proxy statement relating to Anika Therapeutics&#146; Annual Meeting of Stockholders,
(2)&nbsp;to have all required information regarding such candidate included in
the proxy statement relating to Anika Therapeutics&#146; Annual Meeting of
Stockholders filed pursuant to the rules&nbsp;of the SEC and (3)&nbsp;to serve
as a director if elected at such annual meeting; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 5.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>Any
other information regarding the proposed director candidate that is required to
be included in a proxy statement filed pursuant to the rules&nbsp;of the SEC.</p>

<p style="margin:0pt 0pt 11.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Nominating Committee
may solicit recommendations for candidates for directors from non-management
directors, the Chief Executive Officer, other executive officers, third-party
search firms and such other sources as it deems appropriate, including
stockholders. The Nominating Committee will review and evaluate the
qualifications of all such proposed candidates in the same manner and without
regard to the source of the recommendation.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 5.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Communications with the Board of Directors<a name="CommunicationsWithTheBoardOfDirec_104957"></a></font></b></p>

<p style="margin:0pt 0pt 5.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If you wish to communicate
with any of our directors or the Board of Directors as a group, you may do so
by writing to the Board of Directors, or such individual director(s)&nbsp;c/o
Chief Financial Officer, Anika Therapeutics,&nbsp;Inc., 160 New Boston Street,
Woburn, Massachusetts 01801.</font></p>

<p style="margin:0pt 0pt 5.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We recommend that all
correspondence be sent via certified U.S. mail, return receipt requested. All correspondence
received by the Chief Financial Officer will be forwarded by the Chief
Financial Officer (or the person serving the function of Chief Financial
Officer) promptly to the appropriate addressee(s).</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">7</font></p>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='7',FILE='C:\fc\11112254538_D11085_1043602\10148-1-de.htm',USER='jmsproofassembler',CD='Apr 21 12:03 2006' -->



<br clear="all" style="page-break-before:always;">

<div style="font-family:Times New Roman;">

<p style="font-weight:bold;margin:0pt 0pt 5.5pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">AUDIT
COMMITTEE REPORT<a name="AuditCommitteeReport_103115"></a></font></b></p>

<p style="margin:0pt 0pt 5.5pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following report of
the Audit Committee is required by the rules&nbsp;of the Commission to be
included in this Proxy Statement. <font style="letter-spacing:-.1pt;">The Audit
Committee currently consists of Mr.&nbsp;Land, as Chairperson, Dr.&nbsp;Bower
and Mr.&nbsp;Wheeler.</font> In January&nbsp;2006, Samuel F. McKay resigned
from the Board of Directors, and Mr.&nbsp;Land replaced him on the Audit
Committee. Messrs.&nbsp;McKay and Wheeler and Dr.&nbsp;Bower served on the
Audit Committee throughout 2005. Mr.&nbsp;Land qualifies as an &#147;audit committee
financial expert&#148; under the rules&nbsp;of the SEC. The Board of Directors has
determined that each member of the Audit Committee meets the independence
requirements promulgated by Nasdaq and the SEC, including Rule&nbsp;10A-3(b)(1)&nbsp;under
the Exchange Act. <font style="letter-spacing:-.1pt;">During fiscal year 2005,
the Audit Committee met six times.</font></font></p>

<p style="margin:0pt 0pt 5.5pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The purpose of the Audit
Committee is to oversee the Company&#146;s accounting and financial reporting
process and the audits of the Company&#146;s financial statements. During the fiscal
years 2003 through 2005, the Company&#146;s independent registered public accounting
firm was PricewaterhouseCoopers LLP (&#147;PwC&#148;). The Audit Committee operates
pursuant to a written charter adopted by the Board of Directors, a copy of
which is available on the Company&#146;s website.</font></p>

<p style="margin:0pt 0pt 5.5pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As set forth in the Audit
Committee Charter, management of the Company is responsible for the
preparation, presentation and integrity of the Company&#146;s financial statements,
the Company&#146;s financial reporting process, accounting policies, internal
controls and disclosure controls and procedures. PwC is responsible for
auditing the Company&#146;s financial statements and expressing an opinion as to
their conformity with generally accepted accounting principles and on
management&#146;s assessment of the effectiveness of the Company&#146;s internal control
over financial reporting. The Audit Committee&#146;s responsibility is to monitor
and oversee this process.</font></p>

<p style="margin:0pt 0pt 5.5pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In the performance of its
oversight function, the Audit Committee has reviewed and discussed with
management and PwC the audited financial statements and management&#146;s assessment
of the effectiveness of the Company&#146;s internal control over financial reporting
and PwC&#146;s evaluation of the Company&#146;s internal control over financial
reporting. The Audit Committee has also discussed with PwC the matters required
to be discussed by Statement on Auditing Standards No.&nbsp;61, &#147;Communication
with Audit Committees,&#148; as currently in effect. Finally, the Audit Committee
has received the written disclosures and the letter from PwC required by
Independence Standards Board Standard No.&nbsp;1, &#147;Independence Discussions
with Audit Committees,&#148; as currently in effect, has discussed with PwC its
independence in relation to the Company and has considered the compatibility of
non-audit services with such independence. Management has represented to the
Audit Committee that the Company&#146;s consolidated financial statements were
prepared in accordance with generally accepted accounting principles.</font></p>

<p style="margin:0pt 0pt 11.5pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Based upon the review and
discussions referred to above, the Audit Committee recommended to the Board of
Directors that Anika Therapeutics&#146; audited financial statements be included in
the Company&#146;s Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31,
2005 for filing with the SEC.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 11.5pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">SUBMITTED BY THE AUDIT COMMITTEE<a name="SubmittedByTheAuditCommittee_103153"></a><br>
OF THE COMPANY&#146;S BOARD OF DIRECTORS<a name="OfTheCompanysBoardOfDirectors_103116"></a></font></b></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="40%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:40.62%;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt;">Raymond J. Land, Chairperson</p>
  </td>
  <td width="2%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:2.2%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="35%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:35.76%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Joseph L. Bower</font></p>
  </td>
  <td width="2%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:2.64%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="18%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:18.78%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Steven E. Wheeler</font></p>
  </td>
 </tr>
</table>

<p style="line-height:1.0pt;margin:0pt 0pt 11.5pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0pt 0pt 5.5pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">THE FOREGOING REPORT
SHOULD NOT BE DEEMED INCORPORATED BY REFERENCE INTO ANY FILING UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE SECURITIES EXCHANGE ACT OF
1934, AS AMENDED, BY ANY GENERAL STATEMENT INCORPORATING BY REFERENCE THIS
PROXY STATEMENT EXCEPT TO THE EXTENT THAT ANIKA THERAPEUTICS SPECIFICALLY
INCORPORATES THIS INFORMATION BY REFERENCE AND SHALL NOT OTHERWISE BE DEEMED
FILED UNDER SUCH ACTS.</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">8</font></p>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='8',FILE='C:\fc\11112419971_D11085_1043602\10148-1-dg.htm',USER='jmsproofassembler',CD='Apr 21 12:04 2006' -->



<br clear="all" style="page-break-before:always;">

<div>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Directors&#146;
Compensation<a name="DirectorsCompensation_103719"></a></font></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For fiscal year 2005, each director who was not an
employee of Anika Therapeutics received a director&#146;s fee of $20,000. In
addition, each non-employee director was paid $1,000 for each Board
meeting or committee meeting attended in person or regular Board meetings
attended telephonically and $500 for each special Board meeting or committee
meeting attended telephonically. All non-employee directors were
reimbursed for out-of-pocket expenses incurred in attending
meetings of the Board of Directors and any committees thereof. Directors
serving on committees of the Board receive no additional compensation for
attending any committee meeting held in connection with a meeting of the Board.
The Lead Director was entitled to an additional retainer of $10,000 in
compensation for services as Lead Director.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;letter-spacing:-.1pt;">On April&nbsp;25, 2005, </font>each
then current non-employee director was granted immediately exercisable stock
options to purchase 1,275 shares of Anika Therapeutics&#146; common stock <font style="letter-spacing:-.1pt;">under the Anika Therapeutics,&nbsp;Inc. 2003 Stock
Option and Incentive Plan (the &#147;2003 Plan&#148;) </font>in consideration for fiscal
2004 services, at an exercise price of $14.33 per share, a value of
approximately $10,000 based on a Black-Scholes analysis.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For fiscal year 2006, each non-employee director of
Anika Therapeutics will receive a director&#146;s fee of $20,000. In addition, each
non-employee director will be paid $1,000 for each Board meeting or
committee meeting attended in person or regular Board meetings attended
telephonically and $500 for each special Board meeting or committee meeting
attended telephonically. All non-employee directors will be reimbursed
for out-of-pocket expenses incurred in attending meetings of the
Board of Directors and any committees thereof. Directors serving on committees
of the Board will receive no additional compensation for attending any
committee meeting held in connection with a meeting of the Board. The Lead
Director will be entitled to an additional retainer of $10,000 in compensation
for services as Lead Director. On January&nbsp;26, 2006, each non-employee
director was granted stock appreciation rights that were immediately
exercisable for 1,770 shares of common stock under the 2003 Plan at an exercise
price of $10.51 per share, valued at approximately $10,000 using the Black-Scholes
method.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In connection with his appointment to the Board of
Directors, Raymond J. Land was awarded a stock appreciation right under the
2003 Plan on January&nbsp;24, 2006. The stock appreciation right covers 4,500
shares of common stock of Anika Therapeutics and will be settled only in shares
of Anika Therapeutics&#146; common stock at an exercise price of $10.50 per share,
which was equal to the fair market value of a share of Anika Therapeutics&#146;
common stock on January&nbsp;24, 2006. The stock appreciation right vests and
becomes exercisable in four equal yearly installments beginning on January&nbsp;24,
2007, and terminates on the tenth anniversary of the date of grant, unless
earlier terminated as a result of termination of service.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In connection with Samuel
F. McKay&#146;s resignation from the Board of Directors, on January&nbsp;24, 2006,
the Board of Directors extended the exercise period for Mr.&nbsp;McKay&#146;s option
to purchase 1,275 shares of the Anika Therapeutics&#146; common stock until April&nbsp;25,
2015. Mr.&nbsp;McKay&#146;s stock option was originally granted on April&nbsp;25,
2005.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Executive Officers<a name="ExecutiveOfficers_103719"></a></font></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Board of Directors elects our executive officers
annually at a regular meeting held immediately following the Annual Meeting of
Stockholders. Such executive officers hold office until the next annual meeting
unless they sooner resign or are removed from office. There are no family
relationships between any of our directors or executive officers.</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">9</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='9',FILE='C:\fc\11112824619_D11085_1043602\10148-1-di.htm',USER='jmsproofassembler',CD='Apr 21 12:09 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 12.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
following table lists the current executive officers of Anika Therapeutics and
certain information concerning the executive officers of Anika Therapeutics who
are not also directors. It is anticipated that each of these officers will be
re-appointed by the Board of Directors following the Annual Meeting:</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;">
 <tr>
  <td width="29" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:21.8pt;">
  <p align="left" style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt 8.0pt;page-break-after:avoid;text-align:left;text-indent:-8.0pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Name</font></b></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="189" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:142.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="28" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:20.75pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Age</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="40" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:30.0pt;">
  <p align="left" style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Position</font></b></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="276" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:206.8pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="225" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:168.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Charles H. Sherwood,
  Ph.D.</font></p>
  </td>
  <td width="16" valign="top" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="28" valign="top" style="border:none;padding:0pt .7pt 0pt 0pt;width:20.75pt;">
  <p align="center" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">59</font></p>
  </td>
  <td width="16" valign="top" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="322" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:241.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President and Chief
  Executive Officer</font></p>
  </td>
 </tr>
 <tr>
  <td width="225" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:168.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Frank Luppino</font></p>
  </td>
  <td width="16" valign="top" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="28" valign="top" style="padding:0pt .7pt 0pt 0pt;width:20.75pt;">
  <p align="center" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37</font></p>
  </td>
  <td width="16" valign="top" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="322" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:241.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vice
  President&#151;Operations</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="225" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:168.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Carol A. Toth, Ph.D.</font></p>
  </td>
  <td width="16" valign="top" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="28" valign="top" style="padding:0pt .7pt 0pt 0pt;width:20.75pt;">
  <p align="center" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50</font></p>
  </td>
  <td width="16" valign="top" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="322" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:241.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vice President&#151;Research
  and Development</font></p>
  </td>
 </tr>
 <tr>
  <td width="225" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:168.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Kevin W. Quinlan</font></p>
  </td>
  <td width="16" valign="top" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="28" valign="top" style="padding:0pt .7pt 0pt 0pt;width:20.75pt;">
  <p align="center" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">55</font></p>
  </td>
  <td width="16" valign="top" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="322" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:241.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief Financial Officer,
  Treasurer and Secretary</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="225" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:168.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Peter Litman</font></p>
  </td>
  <td width="16" valign="top" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="28" valign="top" style="padding:0pt .7pt 0pt 0pt;width:20.75pt;">
  <p align="center" style="margin:0pt 0pt .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">54</font></p>
  </td>
  <td width="16" valign="top" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="322" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:241.8pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vice President of Business Development and Marketing</font></p>
  </td>
 </tr>
</table>

</div>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr. Luppino was appointed Vice President&#151;Operations of
Anika Therapeutics in June&nbsp;2003. Mr.&nbsp;Luppino was previously Executive
Director of Operations at Anika Therapeutics. Prior to joining Anika
Therapeutics in 1998, Mr.&nbsp;Luppino was Regional Manager for AAC Consulting
Group, a firm serving the pharmaceutical and medical device industries. From
1992 to 1998, he was Regional Manager for Raytheon Engineers and Constructors,
where he executed design, start-up and validation projects for clients in
the pharmaceutical and biotechnology industries. Prior to that, Mr.&nbsp;Luppino
was a Project Engineer with Black and Veatch, an architectural and engineering
design firm. Mr.&nbsp;Luppino holds a bachelor&#146;s degree in chemical engineering
from Lehigh University.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr. Toth was appointed Vice President&#151;Research and
Development of Anika Therapeutics in November&nbsp;2004. Dr.&nbsp;Toth most
recently served as vice president of research and development at Stryker Biotech,
a division of Stryker Corporation, where she managed a 30-person
organization responsible for all research, product development and business
development activities. From 1991 to 1996, Dr.&nbsp;Toth was Associate
Director, pharmaceutical evaluation at T Cell Sciences,&nbsp;Inc. (now AVANT
Immunotherapeutics,&nbsp;Inc.). Between 1986 and 1992, Dr.&nbsp;Toth worked as
a scientist and academic last serving as Assistant Professor, Department of
Surgery, Harvard Medical School. In her earlier capacities, Dr.&nbsp;Toth was
principal investigator for multiple NIH research grants and led various
industrial research collaborations. Dr.&nbsp;Toth earned a doctorate degree in
cellular immunology from Boston University School of Medicine and bachelor of
science degree from Fairfield University.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr. Quinlan was appointed Chief Financial Officer,
Treasurer and Secretary of Anika Therapeutics in July&nbsp;2005. Previously, Mr.&nbsp;Quinlan
was President of BBI Diagnostics, a division of SeraCare, which was acquired in
2004 from Boston Biomedica, Inc (&#147;BBI&#148;). From 1999 to 2004, he served as
President and Chief Operating Officer of BBI, then a publicly traded
manufacturer of quality control products used to monitor infectious disease
testing, and had operational and P&amp;L responsibility for BBI&#146;s five business
units. Mr.&nbsp;Quinlan previously served as Chief Financial Officer of BBI
from 1993 to 2003. As Chief Financial Officer, he was responsible for finance,
IT, treasury, human resources and investor relations. From 1990 to 1993, Mr.&nbsp;Quinlan
was Chief Financial Officer of Parctec, Inc (a subsidiary of Kleinwort Benson
Group). Between 1981 to 1990, Mr.&nbsp;Quinlan was Vice President, Assistant
Treasurer and Corporate Controller of American Finance Group. From 1975 to
1981, Mr.&nbsp;Quinlan was an auditor/senior auditor/audit supervisor at
Coopers&nbsp;&amp; Lybrand. Mr.&nbsp;Quinlan is a Certified Public Accountant
and has degrees from both the University of New Hampshire and Northeastern
University.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr. Litman was appointed Vice President of Business
Development and Marketing in October&nbsp;2005. Prior to joining Anika
Therapeutics, Mr.&nbsp;Litman was Vice President of Corporate Development at
Smith&nbsp;&amp; Nephew, Endoscopy from 2002 to 2005. In that position Mr.&nbsp;Litman
was a member of the executive committee and was responsible for strategic
planning, technology assessment, acquisitions, licensing, risk management, and
divestitures. Prior to joining Smith&nbsp;&amp; Nephew, Mr.&nbsp;Litman was a
co-founder and managing director of Collapeutics in Wellesley from 2000 to
2002. Mr.&nbsp;Litman has also been employed at Summit Technology, Goldstein&nbsp;&amp;
Manello, and Baer, Marks&nbsp;&amp; Upham. Mr.&nbsp;Litman holds </font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">10</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='10',FILE='C:\fc\11112824619_D11085_1043602\10148-1-di.htm',USER='jmsproofassembler',CD='Apr 21 12:09 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 6.0pt;text-indent:0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.A. in English Literature
from the University of Pennsylvania, and a J.D. from Columbia University Law
School.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Executive
Compensation<a name="ExecutiveCompensation_103720"></a></font></b></p>

<p style="font-style:italic;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Summary
Compensation</font></i></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following table sets
forth certain information concerning the compensation, for each of the periods
indicated, of the individuals who have served as Anika Therapeutics&#146; Chief
Executive Officer and the three other most highly compensated executive
officers whose total annual salary and bonus exceeded $100,000 for the year
ended December&nbsp;31, 2005 (of which there were only three such other
qualifying executive officers) (the &#147;Named Executive Officers&#148;).</font></p>

<p style="font-weight:bold;margin:0pt 0pt 12.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Summary
Compensation Table<a name="SummaryCompensationTable_103721"></a></font></b></p>

<div align="center" style="font-family:Times New Roman;">

<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;">
 <tr>
  <td width="204" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:153.1pt;">
  <p style="font-size:8.0pt;font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="173" colspan="9" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:129.6pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="79" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:59.45pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Long-Term<br>
  Compensation</font></b></p>
  </td>
  <td width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:14.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="96" colspan="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:71.7pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="204" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:153.1pt;">
  <p align="left" style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="37" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:27.6pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="120" colspan="5" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:90.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Annual&nbsp;Compensation</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="79" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:59.45pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Securities</font></b></p>
  </td>
  <td width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:14.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="96" colspan="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:71.7pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="204" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:153.1pt;">
  <p align="left" style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="37" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:27.6pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Fiscal</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="border:none;padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="79" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:59.45pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Underlying</font></b></p>
  </td>
  <td width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:14.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="96" colspan="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:71.7pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">All&nbsp;Other</font></b></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="135" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:101.25pt;">
  <p align="left" style="font-size:8.0pt;font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;">Name&nbsp;and&nbsp;Principal&nbsp;Position</p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="62" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:46.85pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="37" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:27.6pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Year</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Salary($)</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Bonus($)</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="79" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:59.45pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Options&nbsp;(No.)(1)</font></b></p>
  </td>
  <td width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:14.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="96" colspan="4" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:71.7pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Compensation($)(2)</font></b></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="204" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:153.1pt;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;">Charles H. Sherwood</p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2005</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">374,423</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">187,500</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50,000</font></p>
  </td>
  <td width="18" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:13.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:14.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="39" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:29.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19,879 </font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.5pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="204" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:153.1pt;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt 20.0pt;page-break-after:avoid;text-indent:-10.0pt;">President and Chief</p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2004</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">358,262</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">230,000</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="18" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:13.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:14.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19,379</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.5pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="204" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:153.1pt;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt 20.0pt;page-break-after:avoid;text-indent:-10.0pt;">Executive Officer</p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2003</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">298,654</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">150,000</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">180,000</font></p>
  </td>
  <td width="18" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:13.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:14.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12,302</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.5pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="204" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:153.1pt;">
  <p style="margin:6.0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Frank Luppino</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2005</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">195,481</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">45,000</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50,000</font></p>
  </td>
  <td width="18" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:13.5pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:14.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9,865</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.5pt;">
  <p style="margin:6.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="204" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:153.1pt;">
  <p style="margin:0pt 0pt .0001pt 20.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vice President&#151;Operations (5)</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2004</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">174,538</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48,750</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="18" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:13.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:14.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8,628</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.5pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="204" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:153.1pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2003</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">148,414</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37,500</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">70,000 </font></p>
  </td>
  <td width="18" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:13.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font></p>
  </td>
  <td width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:14.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7,682</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.5pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="204" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:153.1pt;">
  <p style="font-size:10.0pt;margin:6.0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;">Kevin W. Quinlan</p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2005</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">97,308</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">27,500</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">75,000 </font></p>
  </td>
  <td width="18" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:13.5pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(7)</font></p>
  </td>
  <td width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:14.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5,147</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.5pt;">
  <p style="margin:6.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="204" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:153.1pt;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt 20.0pt;page-break-after:avoid;text-indent:-10.0pt;">Chief Financial Officer (6)</p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2004</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="18" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:13.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:14.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.5pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="204" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:153.1pt;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2003</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="18" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:13.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:14.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.5pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="204" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:153.1pt;">
  <p style="margin:6.0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Carol A. Toth</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2005</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">225,000</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">51,750</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="18" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:13.5pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:14.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11,489</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:6.0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.5pt;">
  <p style="margin:6.0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="204" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:153.1pt;">
  <p style="margin:0pt 0pt .0001pt 20.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vice President&#151;Research and</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2004</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21,635</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">75,000 </font></p>
  </td>
  <td width="18" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:13.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(9)</font></p>
  </td>
  <td width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:14.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30,083 </font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(10)</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.5pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="204" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:153.1pt;">
  <p style="margin:0pt 0pt .0001pt 20.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Development (8)</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2003</font></p>
  </td>
  <td width="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.05pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="18" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:13.5pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:14.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.85pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.5pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="135" style="border:none;"></td>
  <td width="7" style="border:none;"></td>
  <td width="62" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="4" style="border:none;"></td>
  <td width="29" style="border:none;"></td>
  <td width="4" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="7" style="border:none;"></td>
  <td width="45" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="7" style="border:none;"></td>
  <td width="45" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="45" style="border:none;"></td>
  <td width="18" style="border:none;"></td>
  <td width="19" style="border:none;"></td>
  <td width="25" style="border:none;"></td>
  <td width="7" style="border:none;"></td>
  <td width="39" style="border:none;"></td>
  <td width="25" style="border:none;"></td>
  <td width="5" style="border:none;"></td>
 </tr>
</table>

</div>

<div style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><hr size="1" width="160" noshade color="black" align="left" style="width:120.0pt;"></div>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>For additional
information concerning these awards, see the table below under the caption &#147;Option
Grants in Last Fiscal Year.&#148;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Unless otherwise noted,
these amounts constitute group term life insurance premiums and matching contributions
to Anika Therapeutics&#146; Employee Savings and Retirement Plan.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Such amount includes
reimbursement of life insurance premium of $7,315.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Includes 20,000 options
granted on June&nbsp;9, 2003 in connection with Mr.&nbsp;Luppino&#146;s promotion to
Vice President&#151;Operations.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Mr.&nbsp;Luppino was
promoted to Vice President&#151;Operations in June&nbsp;2003.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Mr.&nbsp;Quinlan joined
Anika Therapeutics,&nbsp;Inc. as Chief Financial Officer in July&nbsp;2005.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(7)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Includes 75,000 options
granted on July&nbsp;11, 2005 in connection with Mr.&nbsp;Quinlan&#146;s hiring.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(8)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Dr.&nbsp;Toth joined
Anika Therapeutics,&nbsp;Inc. as Vice President&#151;Research and Development in November&nbsp;2004.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(9)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Includes 75,000 options
granted on July&nbsp;11, 2005 in connection with Dr.&nbsp;Toth&#146;s hiring.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(10)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160; </font>Dr.&nbsp;Toth
received a $30,000 signing bonus in November&nbsp;2004.</p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">11</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='11',FILE='C:\fc\11112824619_D11085_1043602\10148-1-di.htm',USER='jmsproofassembler',CD='Apr 21 12:09 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">OPTION GRANTS IN
LAST FISCAL YEAR<a name="OptionGrantsInLastFiscalYear_105029"></a></font></b></p>

<p style="margin:0pt 0pt 12.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
following table sets forth each grant of stock options made to the Named
Executive Officers during the year ended December&nbsp;31, 2005:</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;">
 <tr>
  <td width="167" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:125.05pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="203" colspan="12" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:152.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Individual Grants</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="56" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.95pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="130" colspan="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:97.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Potential Realizable</font></b></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="167" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:125.05pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="54" colspan="3" valign="bottom" style="border:none;padding:0pt .7pt 0pt 0pt;width:40.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Number&nbsp;of</font></b></p>
  </td>
  <td width="16" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="67" colspan="3" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:50.4pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">%&nbsp;of&nbsp;Total</font></b></p>
  </td>
  <td width="16" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="50" colspan="4" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:37.6pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="56" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.95pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="130" colspan="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:97.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Value at Assumed</font></b></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="167" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:125.05pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="54" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:40.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Securities</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="67" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:50.4pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Options</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="50" colspan="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:37.6pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="56" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.95pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="130" colspan="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:97.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Annual Rates of</font></b></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="167" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:125.05pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="54" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:40.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Underlying</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="67" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:50.4pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Granted&nbsp;to</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="50" colspan="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:37.6pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Exercise</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="56" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.95pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="130" colspan="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:97.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Stock&nbsp;Price&nbsp;Appreciation</font></b></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="167" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:125.05pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="54" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:40.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Options</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="67" colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:50.4pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Employees&nbsp;in</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="50" colspan="4" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:37.6pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Price</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="56" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.95pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Expiration</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="130" colspan="5" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:97.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">for Option Term(3)</font></b></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="29" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:21.8pt;">
  <p align="left" style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Name</font></b></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="131" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:98.25pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="54" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:40.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Granted(1)</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="67" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:50.4pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Fiscal&nbsp;Year(2)</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="50" colspan="4" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:37.6pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">($/Share)</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="56" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:41.95pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Date</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">5%($)</font></b></p>
  </td>
  <td width="16" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="62" colspan="2" valign="bottom" style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:46.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">10%($)</font></b></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="167" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:125.05pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Charles Sherwood</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="39" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:29.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50,000</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:15.7pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.4</font></p>
  </td>
  <td width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:15.7pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.3pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="32" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:24.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.71</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.3pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="56" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.95pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2/10/2015</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">273,884</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">694,075</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="167" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:125.05pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Frank Luppino</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="39" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:29.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50,000</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:15.7pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.4</font></p>
  </td>
  <td width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:15.7pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.3pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="32" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:24.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.71</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.3pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="56" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.95pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2/10/2015</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">273,884</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">694,075</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="167" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:125.05pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Kevin Quinlan</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="39" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:29.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">75,000</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:15.7pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18.6</font></p>
  </td>
  <td width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:15.7pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.3pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="32" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:24.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.24</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.3pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="56" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.95pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7/11/2015</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">530,158</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="55" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,343,525</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="167" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:125.05pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Carol Toth</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.75pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="39" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:29.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.75pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:15.7pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:15.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.3pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="39" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:29.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="6" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.3pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="56" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:41.95pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="62" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:46.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="29" style="border:none;"></td>
  <td width="7" style="border:none;"></td>
  <td width="131" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="8" style="border:none;"></td>
  <td width="39" style="border:none;"></td>
  <td width="8" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="21" style="border:none;"></td>
  <td width="25" style="border:none;"></td>
  <td width="21" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="6" style="border:none;"></td>
  <td width="7" style="border:none;"></td>
  <td width="32" style="border:none;"></td>
  <td width="6" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="56" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="7" style="border:none;"></td>
  <td width="45" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="7" style="border:none;"></td>
  <td width="55" style="border:none;"></td>
  <td width="2" style="border:none;"></td>
 </tr>
</table>

</div>

<div style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><hr size="1" width="160" noshade color="black" align="left" style="width:120.0pt;"></div>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The exercisability of
each option automatically accelerates upon a &#147;Change in Control of the Company&#148;
(as defined in the 2003 Plan, as amended). See &#147;Report of the Compensation
Committee of the Board of Directors on Executive Compensation&#148; for more
information regarding such grants.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A total of 403,150
options to purchase common stock of Anika Therapeutics were granted to our
employees in the year ended December&nbsp;31, 2005.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Represents
the value of options granted at the end of the option terms if the price of
Anika Therapeutics&#146; common stock were to appreciate annually by 5% and 10%,
respectively, from the price at the date of grant. The 5% and 10% assumed rates
of appreciation are required by SEC and do not represent our estimate or
projection of future prices of Anika Therapeutics&#146; common stock.</p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Option Exercises
and Holdings<a name="OptionExercisesAndHoldings_130652"></a></font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following table sets
forth certain information concerning exercises of stock options during the
fiscal year ended December&nbsp;31, 2005 by each of the Named Executive
Officers and the number and value of options held by each of the Named
Executive Officers on December&nbsp;31, 2005.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 12.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">AGGREGATED
OPTION EXERCISES IN LAST FISCAL YEAR<a name="AggregatedOptionExercisesInLastFi_103451"></a><br>
AND FISCAL YEAR-END OPTION VALUES<a name="AndFiscalYearendOptionValues_103451"></a></font></b></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;">
 <tr>
  <td width="29" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:21.8pt;">
  <p align="left" style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Name</font></b></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="116" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:87.3pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="67" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:50.5pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Shares<br>
  Acquired&nbsp;on<br>
  Exercise&nbsp;(No.)</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.15pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="63" colspan="4" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:47.2pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Value<br>
  Realized&nbsp;($)</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="122" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:91.8pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Securities&nbsp;Underlying<br>
  Unexercised&nbsp;Options&nbsp;at<br>
  Fiscal&nbsp;Year&nbsp;End&nbsp;(No.)<br>
  Exercisable/Unexercisable</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="136" colspan="4" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:101.95pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Value&nbsp;of&nbsp;Unexercised<br>
  In-the-Money&nbsp;Options<br>
  at&nbsp;Fiscal&nbsp;Year&nbsp;End&nbsp;($)<br>
  Exercisable/Unexercisable(1)</font></b></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="152" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:114.1pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Charles H.
  Sherwood .</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="39" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:29.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30,000</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.15pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">412,715</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.1pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.25pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="92" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:69.25pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">445,000/165,000</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.3pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:7.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="109" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:81.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3,642,675/$962,038</font></p>
  </td>
  <td width="10" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:7.6pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="152" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:114.1pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Frank Luppino</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="39" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:29.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23,000</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.15pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">319,677</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.1pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.25pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="92" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:69.25pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">79,500/86,500</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.3pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:7.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="116" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:86.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$620,980/$385,840</font></p>
  </td>
  <td width="10" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:7.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="152" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:114.1pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Kevin W. Quinlan</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="39" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:29.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.15pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.1pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.25pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="92" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:69.25pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0/75,000</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.3pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:7.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="116" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:86.75pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$0/$33,750</font></p>
  </td>
  <td width="10" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:7.6pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="152" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:114.1pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Carol Toth</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.95pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="39" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:29.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.75pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.15pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.1pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:4.1pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.25pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="92" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:69.25pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18,750/56,250</font></p>
  </td>
  <td width="15" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.3pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:7.6pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="116" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:86.75pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$38,438/$115,313</font></p>
  </td>
  <td width="10" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:7.6pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
</table>

</div>

<div style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><hr size="1" width="160" noshade color="black" align="left" style="width:120.0pt;"></div>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based
on the fair market value of the Common Stock on December&nbsp;30, 2005 of
$11.69 per share less the applicable option exercise prices ranging from $0.90
to $11.24 per share.</p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">12</font></p>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='12',FILE='C:\fc\11112824619_D11085_1043602\10148-1-di.htm',USER='jmsproofassembler',CD='Apr 21 12:09 2006' -->



<br clear="all" style="page-break-before:always;">

<div>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">REPORT OF THE
COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS ON EXECUTIVE COMPENSATION<a name="ExecutiveCompensation_125931"></a></font></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">During 2005, the Compensation Committee of the Board
of Directors consisted of Dr.&nbsp;Bower, Dr.&nbsp;Davidson, Mr.&nbsp;McKay and
Mr.&nbsp;Wheeler, each of whom was a non-employee Director and
independent for purposes of the Nasdaq listing standards. Mr.&nbsp;McKay
resigned from the Board of Directors and the Compensation Committee in January&nbsp;2006.
The Compensation Committee approves Anika Therapeutics&#146; compensation policies
and oversees Anika Therapeutics&#146; overall compensation program.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The overall objective of Anika Therapeutics&#146; executive
compensation policy is to attract and retain highly qualified executive
officers and motivate them to provide a high level of performance for the
benefit of Anika Therapeutics and its shareholders. The Committee believes that
to accomplish these objectives the compensation packages should provide
executive officers with market competitive base salaries and the opportunity to
earn additional compensation based upon Anika Therapeutics&#146; financial
performance and the performance of Anika Therapeutics&#146; Common Stock. In
considering compensation for Anika Therapeutics&#146; executive officers, the
Compensation Committee relies primarily on an assessment of the individuals&#146;
performance and contribution to Anika Therapeutics, in addition to quantitative
factors such as Anika Therapeutics&#146; financial performance and compensation
trends generally. In this regard the Committee reviews surveys of executive
compensation and information concerning compensation at peer group companies.
The principal components of Anika Therapeutics&#146; compensation policy for its
executive officers are base salary, incentive compensation awards, stock
appreciation rights and stock option grants.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The primary component of compensation for Anika
Therapeutics&#146; executive officers is base salary. Base salary levels for Anika
Therapeutics&#146; executive officers are determined based upon an evaluation of a
number of factors, including the individual&#146;s level of responsibility,
experience, performance and competitive market practices as determined by Anika
Therapeutics&#146; analysis of management compensation surveys, and a review of
other published data relating to executive compensation.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The second principal component of Anika Therapeutics&#146;
compensation policy for executive officers consists of cash bonuses. The
Compensation Committee considers the achievement of financial objectives,
organizational development, business and technical development, and other
relevant factors in its discretion to determine the amounts and timing of the
bonuses. Historically, cash bonuses for the most recently completed fiscal year
are awarded contemporaneously with annual salary adjustments for the new fiscal
year. The Compensation Committee also grants cash bonuses for executive
retention purposes, taking into account, among other things, general industry
practices, as well as special performance bonuses in exceptional circumstances.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The third principal component of Anika Therapeutics&#146;
compensation policy for executive officers consists of grants under the 2003
Stock Option and Incentive Plan. Under this plan executive officers may be
granted stock options or other forms of equity security such as performance
shares, stock appreciation rights or restricted stock. This element of Anika
Therapeutics&#146; compensation policy provides the opportunity for Anika
Therapeutics&#146; executive officers to be compensated based upon increases in the
market price of Anika Therapeutics&#146; Common Stock.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition special incentives are awarded from time
to time reflecting unusual circumstances.</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font style="font-style:italic;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Compensation
of Chief Executive Officer.</font></i></font><i><font style="font-style:italic;">&nbsp;&nbsp; </font></i>In 2004, Dr.&nbsp;Sherwood&#146;s annual salary was
$360,000 and effective January&nbsp;1, 2005, Dr.&nbsp;Sherwood&#146;s annual salary
was increased to $375,000. In determining the compensation for Dr.&nbsp;Sherwood
in 2005, the Compensation Committee evaluated the achievement of corporate,
individual and organizational objectives by Anika Therapeutics in 2004. In
addition, the Compensation Committee took into account information regarding
the compensation paid to other Chief Executive Officers in comparably-sized,
publicly traded companies in the pharmaceutical and medical devices industry
and the relative performance of such companies. The Compensation Committee also
</p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">13</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='13',FILE='C:\fc\111133611135_D11090_1043824\10148-1-dk.htm',USER='jmsproofassembler',CD='Apr 21 13:37 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 6.0pt;text-indent:0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">factored into its
evaluation the aggregate value of all compensation received by the Chief
Executive Officer, including the total beneficial ownership of Anika
Therapeutics represented by the Chief Executive Officer&#146;s &#147;in-the-money&#148;
stock options as compared to the holdings of other comparably situated Chief
Executive Officers.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In February&nbsp;2005, Dr.&nbsp;Sherwood was awarded
stock options to acquire up to 50,000 shares of Common Stock at an exercise
price of $8.71 per share (in connection with compensation adjustments made at
the end of fiscal 2004),&#160; such award
vesting in four equal annual installments. No stock options were granted for
services rendered in fiscal 2005.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In recognition of the achievement of the corporate,
individual and organizational objectives of Anika Therapeutics for the 2004
fiscal year, in January&nbsp;2005 the Compensation Committee awarded Dr.&nbsp;Sherwood
a cash bonus of $180,000. In 2004, Dr.&nbsp;Sherwood received a special
performance cash bonus of $50,000 in recognition of Dr.&nbsp;Sherwood&#146;s efforts
in connection with the negotiation of the license agreement pertaining to the
commercialization of Orthovisc in the United States. In January&nbsp;2006, Dr.&nbsp;Sherwood
was awarded a cash bonus of $187,500 in recognition of the achievement of the
corporate, individual and organizational objectives of Anika Therapeutics for
the 2005 fiscal year.</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font style="font-style:italic;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Deductibility
of Executive Compensation.</font></i></font><i><font style="font-style:italic;">&nbsp;&nbsp; </font></i>The
Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), limits the federal
income tax deductibility of compensation paid to Anika Therapeutics&#146; Chief
Executive Officer and to each of the other four most highly compensated
executive officers. For this purpose, compensation can include, in addition to
cash compensation, the difference between the exercise price of stock options
and the value of the underlying stock on the date of exercise. Anika
Therapeutics may deduct compensation with respect to any of these individuals
only to the extent that during any fiscal year such compensation does not
exceed $1 million or meets certain other conditions (such as stockholder
approval). Considering the Anika Therapeutics&#146; current compensation plans and
policy, Anika Therapeutics and the Compensation Committee believe that, for the
near future, there is little risk that Anika Therapeutics will lose any
significant tax deduction relating to executive compensation. If the
deductibility of executive compensation becomes a significant issue, Anika
Therapeutics&#146; compensation plans and policies may be modified to maximize
deductibility if Anika Therapeutics and the Compensation Committee determine
that such action is in the best interests of Anika Therapeutics.</p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">During 2005, the
Compensation Committee engaged in a comprehensive review of Anika Therapeutics&#146;
overall compensation program. In connection with this review, the Compensation
Committee retained an outside compensation consulting firm to provide advice as
to proper short term and long term compensation levels and incentives,
including the appropriate levels of cash and equity (and forms of equity
compensation). The Compensation Committee expects to complete this review
during fiscal 2006, with the goal of implementing any revisions to the
compensation structure prior to the beginning of 2007.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 12.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">SUBMITTED BY THE COMPENSATION
COMMITTEE OF THE BOARD OF DIRECTORS<a name="TheCompensationCommitteeOfTheBoar_130305"></a></font></b></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;font-family:Times New Roman;width:100.0%;">
 <tr>
  <td width="37%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:37.3%;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt;">Joseph L. Bower</p>
  </td>
  <td width="43%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:43.94%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Eugene A. Davidson</font></p>
  </td>
  <td width="18%" valign="top" style="padding:0pt .7pt 0pt 0pt;width:18.76%;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Steven E. Wheeler</font></p>
  </td>
 </tr>
</table>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

<p style="font-weight:bold;margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">THE FOREGOING REPORT SHOULD NOT BE DEEMED INCORPORATED
BY REFERENCE INTO ANY FILING UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, BY ANY GENERAL STATEMENT
INCORPORATING BY REFERENCE THIS PROXY STATEMENT EXCEPT TO THE EXTENT THAT ANIKA
THERAPEUTICS SPECIFICALLY INCORPORATES THIS INFORMATION BY REFERENCE AND SHALL
NOT OTHERWISE BE DEEMED FILED UNDER SUCH ACTS.</font></b></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">14</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='14',FILE='C:\fc\111133611135_D11090_1043824\10148-1-dk.htm',USER='jmsproofassembler',CD='Apr 21 13:37 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Agreements with
Named Executive Officers<a name="AgreementsWithNamedExecutiveOffic_104023"></a></font></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr. Sherwood has an at-will employment relationship
with Anika Therapeutics, the terms of which are evidenced by an offer letter
which was countersigned by Dr.&nbsp;Sherwood at the commencement of his
employment. Under the offer letter, Dr.&nbsp;Sherwood was awarded, in addition
to his respective salary, a grant of stock options for 75,000 shares of Common
Stock vesting in equal installments over four years, plus bonuses and benefits.
If Anika Therapeutics terminates Dr.&nbsp;Sherwood&#146;s employment without cause,
the offer letter entitles him to severance in the amount of six months current
base salary and six months medical benefits. In the event of a &#147;hostile&#148; change
of control (as defined in the offer letter) and Dr.&nbsp;Sherwood either is not
offered employment with the new company or resigns from employment with the new
company that is not comparable employment, he will be entitled to the same
benefits as if he had been terminated by Anika Therapeutics without cause. Dr.&nbsp;Toth
and Messrs.&nbsp;Luppino and Quinlan also have at-will employment relationships
with Anika Therapeutics and entered into similar offer letters at the
commencement of their employment.</font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr. Sherwood is also party
to a change in control, bonus and severance agreement dated July&nbsp;8, 2002, Mr.&nbsp;Luppino
is party to a change in control agreement dated June&nbsp;9, 2003, Dr.&nbsp;Toth
is party to a change in control agreement dated October&nbsp;6, 2004, and Mr.&nbsp;Quinlan
is a party to a change in control agreement dated July&nbsp;11, 2005. Under
these agreements, each of these officers is entitled to receive certain lump
sum payments and other financial benefits in the event of a change in control
(as defined in the agreement). In the event of a change in control, and if
after such change of control their employment is terminated without cause (as
defined in the agreement), each officer would likely receive an amount,
including all periodic payments, in excess of $100,000.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">2003 Stock Option
and Incentive Plan<a name="a2003StockOptionAndIncentivePlan_103453"></a></font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In 2003, Anika
Therapeutics adopted the 2003 Plan to provide incentives to officers,
employees, non-employee directors and other key persons. The 2003 Plan is
administered by the Compensation Committee of the Board of Directors, which, in
its discretion, may grant stock-based awards, including incentive stock
options, non-qualified stock options, stock appreciation rights, deferred
stock, restricted stock, unrestricted stock, performance shares and dividend
equivalent rights. The 2003 Plan provides that in the event of a &#147;change of
control&#148; as defined in the 2003 Plan, generally all stock options and stock
appreciation rights will automatically become fully exercisable and that the
restrictions and conditions on all awards of restricted stock, deferred stock
awards and performance share awards will automatically be deemed waived. At December&nbsp;31,
2005, the total number of remaining options and shares of Common Stock that may
be issued under the 2003 Plan was 625,576.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Compensation
Committee Interlocks and Insider Participation<a name="CompensationCommitteeInterlocksAn_103453"></a></font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Compensation Committee
consists of Dr.&nbsp;Bower, Dr.&nbsp;Davidson and Mr.&nbsp;Wheeler. None of
these individuals is or formerly was an officer or employee of Anika
Therapeutics.</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">15</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='15',FILE='C:\fc\111133611135_D11090_1043824\10148-1-dk.htm',USER='jmsproofassembler',CD='Apr 21 13:37 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stock Performance
Graph<a name="StockPerformanceGraph_103454"></a></font></b></p>

<p style="margin:0pt 0pt 12.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Set
forth below is a line graph comparing the yearly percentage change in the
cumulative total return on our Common Stock, based on the market price of our
Common Stock with the total return of companies included within the Nasdaq
Stock Market Index and a peer group of companies included within the Nasdaq
Pharmaceutical Index for the period commencing on December&nbsp;31, 2000 and
ending on December&nbsp;31, 2005. The calculation of total cumulative return
assumes a $100 investment in the Anika Therapeutics&#146; Common Stock, the Nasdaq
Stock Market Index and the Nasdaq Pharmaceutical Index on December&nbsp;31,
2000, and the reinvestment of all dividends, of which none have been paid. The
historical information set forth below is not necessarily indicative of future
performance.</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;">
 <tr>
  <td width="274" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:205.2pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.9pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="39" colspan="4" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:29.1pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Dec-00</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="39" colspan="4" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:29.25pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Dec-01</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="39" colspan="4" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:29.35pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Dec-02</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="39" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:29.05pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Dec-03</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="39" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:29.05pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Dec-04</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="39" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:29.05pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Dec-05</font></b></p>
  </td>
  <td width="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.1pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="274" valign="top" style="padding:0pt .7pt 0pt 0pt;width:205.2pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NASDAQ
  Biotechnology Market.</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="22" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:16.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.8pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="22" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:16.65pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">84</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.8pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="22" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:16.7pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">46</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.85pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="32" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:24.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">67</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="32" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:24.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">71</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="32" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:24.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">73</font></p>
  </td>
  <td width="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.1pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="274" valign="top" style="padding:0pt .7pt 0pt 0pt;width:205.2pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NASDAQ US Market.</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.65pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">79</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.8pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.7pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">54</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.85pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="39" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:29.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">81</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="39" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:29.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">88</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="39" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:29.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">89</font></p>
  </td>
  <td width="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.1pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="274" valign="top" style="padding:0pt .7pt 0pt 0pt;width:205.2pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Anika Therapeutics</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:11.9pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.8pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.5pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.8pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.8pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.65pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">128</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.8pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.8pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.7pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">127</font></p>
  </td>
  <td width="5" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:3.85pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="39" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:29.05pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,247</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="39" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:29.05pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,171</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="39" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:29.05pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,496</font></p>
  </td>
  <td width="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:2.1pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="274" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="5" style="border:none;"></td>
  <td width="7" style="border:none;"></td>
  <td width="22" style="border:none;"></td>
  <td width="5" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="5" style="border:none;"></td>
  <td width="7" style="border:none;"></td>
  <td width="22" style="border:none;"></td>
  <td width="5" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="5" style="border:none;"></td>
  <td width="7" style="border:none;"></td>
  <td width="22" style="border:none;"></td>
  <td width="5" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="7" style="border:none;"></td>
  <td width="32" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="7" style="border:none;"></td>
  <td width="32" style="border:none;"></td>
  <td width="16" style="border:none;"></td>
  <td width="7" style="border:none;"></td>
  <td width="32" style="border:none;"></td>
  <td width="3" style="border:none;"></td>
 </tr>
</table>

</div>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0pt 0pt 12.0pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-weight:bold;"><img width="604" height="369" src="g101481dki001.gif" alt="GRAPHIC"></font></b></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">16</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='16',FILE='C:\fc\111133611135_D11090_1043824\10148-1-dk.htm',USER='jmsproofassembler',CD='Apr 21 13:37 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Beneficial
Ownership of Common Stock<a name="BeneficialOwnershipOfCommonStock_130835"></a></font></b></p>

<p style="margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following table
sets forth the beneficial ownership of our Common Stock as of April&nbsp;1,
2006, by:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>each
director;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>each
of the Named Executive Officers named in the Summary Compensation Table set
forth under the caption &#147;Executive Compensation;&#148;</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>each
other person which is known by us to beneficially own 5% or more of our Common
Stock; and</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 30.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>all current directors and
executive officers as a group.</p>

<div align="center" style="font-family:Times New Roman;">

<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;">
 <tr>
  <td width="81" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:60.8pt;">
  <p align="left" style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Beneficial&nbsp;Owner</font></b></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="288" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:216.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="104" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:77.8pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Number&nbsp;of&nbsp;Shares<br>
  Beneficially&nbsp;Owned(1)</font></b></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.05pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="73" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:55.1pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Percentage&nbsp;of<br>
  Common&nbsp;Stock<br>
  Outstanding(2)</font></b></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.25pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="376" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:281.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Joseph L. Bower</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">107,891 </font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.02</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.25pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="376" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:281.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Eugene A.
  Davidson, Ph.D.</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">78,971 </font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.25pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="376" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:281.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Raymond J. Land</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,770 </font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.25pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="376" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:281.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Harvey S. Sadow,
  Ph.D.</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32,471 </font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6)</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.25pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="376" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:281.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Steven E. Wheeler</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">96,441 </font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.25pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="376" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:281.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Charles H.
  Sherwood, Ph.D.</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">502,500 </font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(7)</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.54</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.25pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="376" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:281.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Frank Luppino</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">98,500 </font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(8)</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.25pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="376" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:281.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Kevin Quinlan</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.25pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="376" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:281.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Carol Toth, Ph.D</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18,750 </font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(9)</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.25pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="376" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:281.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All current
  directors and current executive officers as a group (9&nbsp;persons)</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">937,294 </font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(10)</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.26</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.25pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="376" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:281.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Other Principal Stockholders:</font></i></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.25pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="376" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:281.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Federated
  Investors,&nbsp;Inc., Federated Investors Tower, John F. Donahue, Rhodora J.
  Donahue and J. Christopher Donahue<br>
  Pittsburgh, PA 15522</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">621,200 </font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(11)</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.88</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.25pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="376" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:281.8pt;">
  <p style="font-size:10.0pt;margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Herbert H.
  Hastings and Euretta L. Hastings<br>
  c/o Morrison&nbsp;&amp; Foerster LLP<br>
  19900 MacArthur Blvd., 12</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">th</font>&nbsp;Floor<br>
  Irvine, CA 92612-2445</p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">731,200 </font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(12)</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.92</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.25pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="376" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:281.8pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ashford Capital
  Management,&nbsp;Inc.<br>
  P.O.&nbsp;Box 4172<br>
  Wilmington, DE 19807</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.05pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">734,300 </font></p>
  </td>
  <td width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:21.9pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(13)</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.05pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:19.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.95</font></p>
  </td>
  <td width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:18.05pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>
  </td>
  <td width="14" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:10.25pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
</table>

</div>

<div style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><hr size="1" width="160" noshade color="black" align="left" style="width:120.0pt;"></div>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Indicates less
than 1%.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The number of shares
deemed beneficially owned includes shares of Common Stock beneficially owned as
of April&nbsp;1, 2006. The inclusion of any shares of stock deemed beneficially
owned does not constitute an admission of beneficial ownership of those shares.
Any reference below to shares subject to outstanding stock options and stock
appreciation rights held by the person in question refers to stock options and
stock appreciation rights that are exercisable within 60&nbsp;days after April&nbsp;1,
2006.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The number of shares
deemed outstanding includes 10,572,395 shares of Common Stock outstanding as of
April&nbsp;1, 2006, plus any shares subject to outstanding stock options and
stock appreciation rights that were exercisable within 60&nbsp;days of April&nbsp;1,
2006, held by the person or persons in question.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This amount includes
48,971 shares subject to stock options and stock appreciation rights that are
exercisable on or before May&nbsp;31, 2006.</p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">17</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='17',FILE='C:\fc\111133611135_D11090_1043824\10148-1-dk.htm',USER='jmsproofassembler',CD='Apr 21 13:37 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This amount includes (i)&nbsp;48,971&nbsp;shares
subject to stock options and stock appreciation rights that are exercisable on
or before May&nbsp;31, 2006 and (ii)&nbsp;1,400&nbsp;shares owned by Dr.&nbsp;Davidson&#146;s
spouse, with respect to which Dr.&nbsp;Davidson disclaims beneficial ownership.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This amount represents
1,770 shares subject to stock appreciation rights that are exercisable on or
before May&nbsp;31, 2006.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This amount includes
22,971 shares subject to stock options and stock appreciation rights that are
exercisable on or before May&nbsp;31, 2006.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(7)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This amount represents
502,500 shares subject to stock options that are exercisable on or before May&nbsp;31,
2006.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(8)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This amount represents
98,500 shares subject to stock options that are exercisable on or before May&nbsp;31,
2006.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(9)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This amount represents
18,750 shares subject to stock options that are exercisable on or before May&nbsp;31,
2006.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(10)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160; </font>This amount includes 791,404
shares in the aggregate subject to stock options and stock appreciation rights
that are exercisable on or before May&nbsp;31, 2006.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(11)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160; </font>Such information is provided
based upon information contained in the Schedule&nbsp;13G/A publicly filed by
Federated Investors,&nbsp;Inc. on February&nbsp;14, 2006 for calendar year
2005.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(12)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160; </font>Such information is provided
based upon information contained in the Schedule&nbsp;13G/A publicly filed by Mr.&nbsp;and
Mrs.&nbsp;Hastings on February&nbsp;6, 2006 for calendar year 2005.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 12.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(13)</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160; </font>Such
information is provided based upon information contained in the
Schedule&nbsp;13G publicly filed by Ashford Capital Management,&nbsp;Inc. on February&nbsp;13,
2006 for calendar year 2005.</p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;16(a)&nbsp;Beneficial
Ownership Reporting Compliance<a name="Section16abeneficialOwnershipRepo_104710"></a></font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Exchange Act requires
that Anika Therapeutics&#146; officers, directors and persons who own more than 10%
of Anika Therapeutics&#146; Common Stock file initial reports of ownership and
reports of changes in ownership with the SEC and Nasdaq. Officers, directors
and persons who beneficially own more than 10% of Anika Therapeutics&#146; Common
Stock are also required to furnish us with a copy of all forms they file
pursuant to Section&nbsp;16(a)&nbsp;of the Exchange Act. To Anika Therapeutics&#146;
knowledge, based solely upon a review of Forms 3, 4 and 5 and amendments
thereto furnished to us under Rule&nbsp;16a-3(e)&nbsp;of the Exchange Act
for the year period ended December&nbsp;31, 2005, no officer, director or
person who owns more than 10% of Anika Therapeutics&#146; outstanding shares of
Common Stock failed to file such reports on a timely basis.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certain Relationships
and Related Transactions<a name="CertainRelationshipsAndRelatedTra_104712"></a></font></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">None.</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">18</font></p>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='18',FILE='C:\fc\111133611135_D11090_1043824\10148-1-dk.htm',USER='jmsproofassembler',CD='Apr 21 13:37 2006' -->



<br clear="all" style="page-break-before:always;">

<div>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM<a name="IndependentRegisteredPublicAccoun_103059"></a></font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The accounting firm of
PricewaterhouseCoopers LLP has served as Anika Therapeutics&#146; principal
independent auditor since the fiscal year 2002. A representative of
PricewaterhouseCoopers LLP is expected to be present at the Annual Meeting of
stockholders and will have the opportunity to make a statement if he desires to
do so and will be available to respond to appropriate questions from
stockholders.</font></p>

<p style="font-style:italic;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fees Paid to Anika
Therapeutics&#146; Principal Independent Auditor</font></i></p>

<p style="margin:0pt 0pt 12.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
following table summarizes the fees that Anika Therapeutics paid or accrued for
audit and other services provided by its principal independent auditor for each
of the last two fiscal years:</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;">
 <tr>
  <td width="62" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:46.5pt;">
  <p align="left" style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">Fee&nbsp;Category</font></b></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="293" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:220.1pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">2005</font></b></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;">2004</font></b></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="font-weight:bold;line-height:8.0pt;margin:0pt 0pt .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="362" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:271.6pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Audit fees</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">380,000</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="45" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">579,000</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="362" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:271.6pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Audit-related
  fees</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr bgcolor="#CCEEFF">
  <td width="362" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:271.6pt;">
  <p style="margin:0pt 0pt .0001pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tax fees</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">71,000</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="52" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:39.0pt;">
  <p style="margin:0pt 0pt .0001pt;page-break-after:avoid;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">59,000</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="362" colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt;width:271.6pt;">
  <p style="margin:0pt 0pt .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total fees</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="45" valign="bottom" style="border-bottom:double windowtext 2.25pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">451,000</font></p>
  </td>
  <td width="16" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:12.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="7" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;width:5.0pt;">
  <p align="left" style="margin:0pt 0pt .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="45" valign="bottom" style="border-bottom:double windowtext 2.25pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:0pt .7pt 0pt 0pt;width:34.0pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">638,000</font></p>
  </td>
  <td width="2" valign="bottom" style="padding:0pt .7pt 0pt 0pt;width:1.7pt;">
  <p style="margin:0pt 0pt .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
</table>

</div>

<p style="line-height:1.0pt;margin:0pt 0pt 12.0pt;"><font size="1" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For purposes of the
preceding table:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>Audit
fees consist of fees for the audit of our consolidated financial statements,
the review of the interim financial statements included in our quarterly
reports of Form&nbsp;10-Q, and other professional services provided in
connection with statutory and regulatory filings or engagements for those
fiscal years. For 2005, audit fees also include the audit of (a)&nbsp;management&#146;s
assessment of internal control over financial reporting and (b)&nbsp;the
effectiveness of internal control over financial reporting, as required under Section&nbsp;404
of the Sarbanes-Oxley Act of 2002.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>Audit-related
fees consist of fees for assurance and related services that are reasonably
related to the performance of the audit and the review of our financial
statements and that are not reported under &#147;Audit fees&#148; for those fiscal years.
These services include, among other things, accounting consultations and advisory
services related to compliance with Section&nbsp;404 of the Sarbanes-Oxley
Act.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>Tax
fees consist of fees for tax compliance, tax advice and tax planning services
for those fiscal years. Tax fees are primarily for tax compliance services
which relate to preparation and review of original and amended tax returns,
claims for refunds and tax payment-planning services. Tax studies, tax
advice and tax planning services relate to miscellaneous items.</p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In considering the nature of the services provided by
the principal independent auditor, the Audit Committee determined that such
services are compatible with the provision of independent audit services. The
Audit Committee discussed these services with the independent auditor and Anika
Therapeutics&#146; management to determine that they are permitted under the rules&nbsp;and
regulations concerning auditor independence promulgated by the SEC to implement
the Sarbanes-Oxley Act of 2002, as well as the American Institute of
Certified Public Accountants<b><font style="font-weight:bold;">.</font></b></font></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Under its charter, the Audit
Committee must pre-approve all audit and permitted non-audit
services to be provided by our principal independent auditor unless an
exception to such pre-approval exists under the Exchange Act or the rules&nbsp;of
the SEC. Each year, the Audit Committee approves the retention of the
independent auditor to audit our financial statements, including the associated
fee. At this time, the Audit Committee evaluates other known potential
engagements of the independent auditor, including the scope of audit-related
services, tax services and other services proposed to be performed and the
proposed fees, and approves or rejects each service, taking into account
whether the services are permissible under </font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">19</font></p> <br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='19',FILE='C:\fc\1111292926_D11085_1043602\10148-1-dm.htm',USER='jmsproofassembler',CD='Apr 21 12:09 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 12.0pt;text-indent:0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">applicable
law and the possible impact of each non-audit service on the independent
auditor&#146;s independence from management. Since the May&nbsp;2003 each new
engagement of PricewaterhouseCoopers has been approved in advance by the Audit
Committee.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">OTHER MATTERS<a name="OtherMatters_103354"></a></font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Board of Directors
does not know of any other matters which may come before the Annual Meeting.
However, if any other matters are properly presented at the Annual Meeting, it
is the intention of the persons named in the accompanying proxy to vote, or
otherwise act, in accordance with their judgment on such matters.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">SOLICITATION
EXPENSES<a name="SolicitationExpenses_103357"></a></font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All costs of solicitation
of proxies will be borne by Anika Therapeutics. In addition to solicitations by
mail, our directors, officers and employees, without additional remuneration,
may solicit proxies in person or by telephone, e-mail, telegraph and facsimile.
Anika Therapeutics may retain a proxy solicitation firm to assist in the
solicitation of proxies for a fee plus reimbursement of expenses.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">STOCKHOLDER
PROPOSALS<a name="StockholderProposals_103400"></a></font></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stockholder proposals intended to be presented at the
next annual meeting of stockholders must be received by Anika Therapeutics on
or before December&nbsp;29, 2006 in order to be considered for inclusion in our
proxy statement. These proposals must also comply with the rules&nbsp;of the
SEC governing the form and content of proposals in order to be included in our
proxy statement and form of proxy and should be directed to: Secretary, Anika
Therapeutics,&nbsp;Inc., 160 New Boston Street, Woburn, Massachusetts 01801. A
stockholder who wishes to present a proposal at the next annual meeting of
stockholders, other than a proposal to be considered for inclusion in our proxy
statement described above, must have the proposal delivered personally to or
mailed to and received by the Secretary, Anika Therapeutics,&nbsp;Inc., 160 New
Boston Street, Woburn, Massachusetts 01801. We must receive the proposal on or
before March&nbsp;26, 2007; provided, however, that such proposal shall not be
required to be given more than 60&nbsp;days prior to the annual meeting of
stockholders. The proposal must also comply with the other requirements
contained in our Amended and Restated By-laws, including supporting
documentation and other information. Proxies solicited by the Board of
Directors will confer discretionary voting authority with respect to these
proposals, subject to SEC rules&nbsp;governing the exercise of this authority.</font></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The chairman of the meeting may, if the facts warrant,
determine and declare to the meeting that any proposed item of business was not
brought before the meeting in accordance with the foregoing procedure and, if
he should so determine, he shall so declare to the meeting that the defective
item of business shall be disregarded.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">STOCKHOLDERS MAY&nbsp;OBTAIN,
WITHOUT CHARGE, A COPY OF ANIKA THERAPEUTICS&#146; ANNUAL REPORT ON FORM&nbsp;10-K,
INCLUDING THE FINANCIAL STATEMENTS AND SCHEDULES THERETO, FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION FOR THE YEAR ENDED DECEMBER 31, 2005, BY
WRITING TO THE SECRETARY, ANIKA THERAPEUTICS,&nbsp;INC., 160 NEW BOSTON STREET,
WOBURN, MASSACHUSETTS 01801.</font></b></p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHETHER OR NOT YOU PLAN TO ATTEND THE ANNUAL MEETING,
YOU ARE URGED TO COMPLETE, DATE, SIGN AND RETURN THE ENCLOSED PROXY IN THE
ACCOMPANYING ENVELOPE. STOCKHOLDERS WHO ATTEND THE MEETING MAY&nbsp;VOTE THEIR
STOCK PERSONALLY EVEN THOUGH THEY HAVE SENT IN THEIR PROXY.</font></p>


 <p style="font-size:10.0pt;margin:24.0pt 0pt .0001pt;text-align:center;"><font face="Times New Roman">20</font></p>
</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='20',FILE='C:\fc\1111292926_D11085_1043602\10148-1-dm.htm',USER='jmsproofassembler',CD='Apr 21 12:09 2006' -->



<br clear="all" style="page-break-before:always;">

<div>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">ANNUAL MEETING OF
STOCKHOLDERS OF<br>
ANIKA THERAPEUTICS,&nbsp;INC.<br>
Thursday, June&nbsp;1, 2006</font></b></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Please date, sign
and mail your proxy card in the envelope provided as soon as possible.</font></b></p>

<p style="font-style:italic;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;">Please detach along
perforated line and mail in the envelope provided.</font></i></p>

<p style="font-size:10.0pt;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Board of Directors recommends a vote &#147;FOR&#148; the
Election of Directors. Please sign, date and return promptly in the enclosed
envelope. Please mark your vote in blue or black ink as shown here </font><font face="Wingdings">x</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>ELECTION OF
DIRECTORS: to serve as Class&nbsp;I Director for a term of three years.</p>

<p style="margin:0pt 0pt 6.0pt;page-break-after:avoid;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Nominees:</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 60.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">o</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Joseph L.
Bower</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 60.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">o</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Eugene A.
Davidson, Ph.D.</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160; FOR ALL NOMINEES</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160; WITHHOLD AUTHORITY FOR ALL NOMINEES</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160; FOR ALL EXCEPT</p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(See instructions
below)</font></p>

<p style="font-size:10.0pt;margin:0pt 0pt 6.0pt;page-break-after:avoid;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Instruction: To
withhold authority to vote for any individual nominee(s), mark &#147;FOR ALL EXCEPT&#148;
and fill in the circle next to each nominee you wish to withhold, as shown
here: </font><font face="Wingdings">l</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0pt 0pt 6.0pt 20.0pt;text-indent:-20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In their
discretion, the proxies are authorized to vote upon such other matters as may
properly come before the meeting or any adjournment or postponement thereof.</p>

<p style="margin:0pt 0pt 6.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN
THE MANNER DIRECTED BY THE UNDERSIGNED STOCKHOLDER. IF NO DIRECTION IS GIVEN,
THIS PROXY WILL BE VOTED IN FAVOR OF ALL NOMINEES IN PROPOSAL 1.</font></p>

<p style="font-size:10.0pt;margin:0pt 0pt 6.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To change the address on your account, please check
the box at right and indicate your new address in the address space above.
Please note that changes to the registered name(s)&nbsp;on the account may not
be submitted via this method. </font><font face="Wingdings">o</font></p>

<p style="font-size:10.0pt;font-weight:bold;margin:0pt 0pt 6.0pt 10.0pt;page-break-after:avoid;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Mark &#147;X&#148; here if you plan to attend
the meeting. </font></b><font face="Wingdings" style="font-weight:normal;">o</font></p>

<p style="margin:0pt 0pt 6.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Signature of Stockholder ______________________ Date:</font></p>

<p style="margin:0pt 0pt 6.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Signature of Stockholder ______________________ Date:</font></p>

<p style="margin:0pt 0pt 6.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Note: Please sign exactly as your name or names appear
on this Proxy. When shares are held jointly, each holder should sign. When
signing as executor, administrator, attorney, trustee or guardian, please give
full title as such. If the signer is a corporation, please sign full corporate
name by duly authorized officer, giving full title as such. If signer is a
partnership, please sign in partnership name by authorized person.</font></p>

<br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\fc\11011114400_D11085_1040260\10148-1-ma.htm',USER='jmsproofassembler',CD='Apr 20 11:11 2006' -->
<br clear="all" style="page-break-before:always;">


<p style="margin:0pt 0pt 6.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">ANIKA
THERAPEUTICS,&nbsp;INC.<br>
ANNUAL MEETING OF STOCKHOLDERS<br>
Thursday, June&nbsp;1, 2006</font></b></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">THIS PROXY IS
SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS</font></b></p>

<p style="margin:0pt 0pt 12.0pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The undersigned, having
received notice of the meeting and management&#146;s proxy statement furnished
herewith, revoking all prior proxies, hereby appoints Dr.&nbsp;Charles H.
Sherwood and Mr.&nbsp;Kevin W. Quinlan, and each of them, with full power of
substitution, as proxies to represent and vote all shares of common stock which
the undersigned would be entitled to vote, if personally present, at the Annual
Meeting of Stockholders of Anika Therapeutics,&nbsp;Inc. (the &#147;Company&#148;) to be
held at the offices of Goodwin Procter LLP, 53 State Street, Boston,
Massachusetts, on Thursday, June&nbsp;1, 2006, at 10:00&nbsp;a.m., and at any
adjournment or postponement thereof, with respect to the matters set forth on
the reverse side. Any proxy may be revoked by a stockholder at any time before
its exercise by delivery of written revocation or a subsequently dated proxy to
the Secretary of the Company or by voting in person at the meeting. Attendance
of the stockholder at the meeting or any adjournment or postponement thereof
will not in and of itself constitute revocation of this proxy.</font></p>

<p style="font-weight:bold;margin:0pt 0pt 6.0pt;page-break-after:avoid;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Continued and to
be signed on the reverse side)<a name="continuedAndToBeSignedOnTheRevers_112852"></a></font></b></p>

</div><br><hr size="3" width="100%" noshade color="#010101" align="center">

<!-- SEQ.=1,FOLIO='',FILE='C:\fc\11011114400_D11085_1040260\10148-1-ma.htm',USER='jmsproofassembler',CD='Apr 20 11:11 2006' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g101481dki001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g101481dki001.gif
M1TE&.#EA6P)Q`?0```$!`0L+"Q,3$QP<'",C(RLK*S0T-#L[.T5%14U-35)2
M4EM;6V%A86QL;'5U=7IZ>H.#@XN+BY:6EIR<G*6EI:NKJ[.SL[N[N\/#P\K*
MRM/3T]S<W./CX^WM[?7U]?[^_B'Y!```````+`````!;`G$!``7^X">.9&F>
M:*JN;.N^<"S/=&W?>*[O?.__P*!P^/&<C"AD24EL.I_0J'1*K5JOV""3F>UZ
MO^"P>$PN>ST6$YK2*64H&=,[;J[;[_B\?L\W40),%@&#`15%'PX`B@E('0>*
M``M]DY25EI>8F!D2`@)*&@`,'AX-`!L?%``2'Q<`#R(*`1@>J1"'F;BYNKN\
MO30>!8H#1D8,!",>#'$'"8</`A\=`!2'#@,]7%+94=M0W4_?3N%-XT3E0^="
MZ5IU;1&`(P,.T4H>`A&'K1T8IH<6`!Q\"1Q(L*#!.T8DP(L60,("``$0Q)%F
MR,@&4W\^`<"`;,,&#A]#@N30@8/)CR?^3:I$J;+E2)8C4\)TN;+ES)DN1=:4
M29,FS)L]:_X4&M2FT:-!=:;D672ITZ<^8SI56G0HTIY465)->E4J5J]:O7+=
M2?:KU9=-GP*M"I9HVK-0<[9EVA2N6+EG<7)8YR+A0@Z#$%BP8$!`!VD7#G$`
ML"D`B<4<C61(H*"RY<L$#B#8S+FSY\^@0XL>3;JTZ=.H4ZM>S;JUZ]>P8\N>
M3;NV[=NX8R<@8(B'WQ'2$``/@`]`Q0\7WP#0R-&%@H#9MI4+5T\-">DLJ".S
MOIV["NTBHE\_DOU[]_'GT9M/47V)^O=)UM]ZCWT%^/GIZ\LG']X[_O3QL0<@
M?OH):.!_!/+^MU]_AT"P"E\M2+!<>`'8,LH'!$A"7#X`[-./$?\$Y)R(!Y5H
MXHDH3N+@#PJ18(`D%+["C#/02$.-$=;`\%R*//;HXX]4&+&B;Q](2`PJJHS"
M0`"GI"(!&JZ(L$``%]`"`#XO)$`BD%QVZ>67,JP((0L4#$-"(H0<]P`D"C2"
M`"2BZ+@EF'36:2>70V*3S0846-`&"7S200(&%&@@PXYW)JKHH@,)^2`NB#(J
MZ:24JKB*-P&Z=^B<E7;JZ:=8.(H@)9&":NJIJ!*19R:EINKJJ[#&(&HN6L9J
MZZVXGK`J)JWFZNNOIHH)*:?`%FMLHK,.>^RRS-XI+*O$-BOMM)/^'!GFI<I2
MJ^VV>&Q0P+<%&##`!#'L>DFOW*:K;A89!`")(K;T]<&SO$:[[KWX.M$N).[B
MLXZYEJ";[\`$^Z"!N^_Z^P+`E0A<\,,0RVI$*OQ>^8*H8Y;A<,0<=ZQI!P^]
MJXC"+C!,2:T>IZRR"0H%X(`"""0@\P&]M8!QMBOG'+%D!@"0P"DV)`NMSD03
M3$PI`Z0Q7\;S/CITT5#?2X$`KC!MG<F3H!SUULU>N,$C"`#-`[V7:,WUV<9Z
ML*8`U&#3-!#?B&?=F!NC;?>I2%@P```-6-L#V0';>_?@H'*0```'".J#T#MX
M4',)'+0]PB:)E7"!!(J/2/CFJ'H``43^Y(ZZ`]8U9'0"`M",4(HB"#32L[L+
M\%4WY[3;>0$!H?RI*K8Z8/".F=M%``#PJ5##SSP?Q!+'/Q9J7OOS=S:B```%
M-&?.VU8O$4P`GE@^P`+=?S"C$<]$,TTUU[PP._3L-YK$.Q8SN+MO1KRSQ``2
MI!+>/1QRT`IT'PB1^@37O@*:*`,%",`"="<.[/7`2"10P`$^8#_SU>PB&C"=
M"$!A/0^8I"0?5$D'$I`!$)8$A"1)(0I/2!(6IE"%(63A"D4(PQ#&\(4M?*$)
M=8C#$^Y0AC1T(0R!:,,ATO"&,Q1B$GL81";&\(<U-"(270A%(\X0B4>48@YW
M6$,EYM"*35S^(A&9Z$4LFI&,3M1B$J'HQ39NT8945&,8LSC&P_"0AR#T0`<8
M``"VZ7&.1Q1C%->80@\X@'<Y\(L2.!&0=QAA,8EY9``:TQ_('"(#E\ED901`
M&4UZ\I.@#*4H1TG*4IKRE*A,I2I7R<I6NO*5L(RE+&=)RUJ>,@$,4`#N`F``
M!2S`EJ1<``$DIP-%BF`##1G%._9"D4-@4(,?X."HN*"U+20H/$CP6W^R><UM
MTF=IM]#F(<2CS7)V\T+6W$XZO>G-=8[SF^U19X*LN<X+O7,\W'2G.>7)3G&*
M\YWTQ*=ZT`G/@K;3H/*[YW^.%%!^RL^>_@QG-Q4Z3WY&%`D9>,3^S[!Y';F=
MAZ#YD2CC=*`0)*0"89!HP`<$T+P0\>,4(`+(``U(4X,0(Q$#>)P5`!>T(BVD
M`X.I``8:$``X?&`S-#+?C3[0@&/,M*90%<C4`."`?W+#@3QHT0DJ^($*7,EQ
M`(C7E"S@`0F1C`7KBZI:$7+,-QW`4%\@G0PF!CQB)`1X'UB3(F(7GL,I0J5R
M6JM@JQ6>M1$S"S=S6Z9$P($*P)4$&:B`V)XZV,KJP0*XBY,8Y+J''67/LJ!5
M!V,/9P`Z?!8(/+VJ@@(;VM:&P0/O:$@=.*N'M+KVMNSX``:"L<"$?B&Q]<*M
M<*D`,@`0H#FGG5\N;#O<YN*@9?'"`VW^\\!<YUHW!AGHF6?9FMI)5/>ZX(U/
M!Y"FM.1"8;IX,%MXUWLQ$4SU`>:]:G?[\%WV@M<(&@#;!N([!?3>0;WV#?`1
M<*K3/LR7#_45\'#U1E7^!NEMRR6@@JUK$;>:]A+^M4.")PQ:S_4Q=`[>*2+/
M)6$.NQ8)M\O=+@[<V1*;N+4<F%X!XA#B*XPT<"\.;VRQU`L6U];%.8XJ$G8+
M`$35N`L9KL.&@UR'43CYR`;9HW$KYXL;-PS(3,[#!@C`92X+('220L($W!5=
M@B39#`#.LB4R\*Y^4?1.V?49`-WGXSRD6<V4V)<BW$S.+AUM>.4]2)WQL&0\
MAX'-(@O``!#^T``)7&"_`H)R'=XKZ3*<^0?=@%"A#?V%@U4,`0PH`-7VO.A&
M/_H^OMB`6^%:Z==BM7&<\B`#P].!Z.QE4YRVA&1$%K\/<.`-$%A`8?A5:D=#
M>K&5((9A?71I%6``K_,:M=8J0#7^C0`"[OIR##:=ZRQP`&R5$8P*?DT!""A@
MV*1FM+$S+;HZ,+AO[2[(H&WVM850T!5O$(`!1,!F!6`@$6W[W`,P\)`"JX#;
MW;:"$1*0OOA\@]SF-@!*`T``=9_:X6-`@N$`4%H\C3AH/1N>$@2@4B/P(S$)
MV+>4CN&!"AWBW#"X<\+QP&:%I<.>)X#XN2=>[(LGH=7EF=<@+@7^=#,`]P8>
MN,"_%P*,R/CZ?`)XQ<26PV9#37W6!\?RS,.@@/`)H0/`/O>H(4*`!!S2YU[`
M`.YZZZ5FIP""Z!'>7L[';XP$H`V[5AQ!T6D$!<#4KG8M0N#Y3O@G`U[P@T>\
MX!?/=\8C'O"&5_S@)P]0RN^]\8?'O.7'B7G)6S[Q3WY\Z)WL><Y_GO$,);WA
M51_YU1.^])D_/4A33WI06$CSID>][EWO'@]B8`(/2$`"(2&``BC@[+=60^LG
MOW?/,]_7#SGNXQW/^MUO?O2\5[WUJ;_]RX,>]VZWCE:74`I\0%(Q`-#`F!^S
MD4M21F;OC_^B+=-)F2F@_N^OC/WU?__^_O,___AW?_'W?_DG@`9H?YW4?P6H
M@`((@`.(?PAX@`48@1)H@`HX@0\(@/J7@03H?PCX@/3'@/\G@A]H@2!8@13(
M@`FH@2.X@BJX@15X@1[(@?`'?_Q7&;C#@B6X?R>X@Q!8@_NW``O``$*8``=`
M``/0"8/P+L7W+09@``B@``PPA;FT@378@"6(A4#X2Q*G:`FP`#:X@S`8@&1X
M@B_8@A$HAE@H@Q38AASH@?TW`$M53$4R(20P9D7%6``024^7`>OG3.U':[5V
M&(>A1[66`!I@B(5(B(HXB(NH1XTX"H[XB(M8B83HB(J8B8PXB)$(B9<HB9^X
MB908BI9HB*;^*(JDJ(FE6(FJF(JHJ(F>R(BQ.(JM*(JM"(N36&NSJ(NY*(F1
MB(FH:(NON(F=6(AL-@_":(G).(FW2(R7*(ND5P3D]@!BQX0'L``18`$EM`6@
M^(R,:!TIMB.NR(K!V(R46(S%2(K,F(OK2([MJ(YM\``?]USV]@$/\0!X5P0;
M8G(`(4`BT`J3M0((MW51D`A:%RK3*&QC%P`%8'83@`')QQX54`%!50$9D`@$
M0&5V,F\N4%(C\``!\%@C4``,<`@E=1%\Z$B419!-]G0E9W3MYD%O0(W#MV=E
MAWQ,<!&\5C7Q!B0F`U+R\H<BP%+(H1+UPQC1\#TB<``%\$@"4)+^*\F2=;`F
M`9D'5L58A$*3$W>3%$`Q[V(`54DG1X=T=8@$H,!KD?0("30`(I(!`L!+U(-E
M`RF50]`!`0"5N(!S2T!N#B!\*"4R9V4G([4!$2`!ACD!A1(#_H,,%]"8CGD!
M?U)6"P`!#,0!YO8D,2!S=-D%0I)^`G&51=`!7@D1O;8HYG)2(@-O&G:0F\D-
M`J``/;D+?J.3>V8Q19=L$-8?7G67#=``CQ`E-1!/[-11,S"7K>D#PI,Y*7*6
M"3,I9),*7O<0`X!U8F"<Q]DXB\8E28<!C\F:*"(T4V<8A\`/>[B:URD&$Q"(
M"O:<?:0[@*$*YGF>8)`98`*:8IF;(P#^G4K0`51#+K=)`]8IG[^`)'RXGB/F
M5>*Y:^6I9-XIH#_P+1P&GDCB=9\C``T*!9KIH$_P#P9G7V2#H"7$`6,6"K&)
M!0&JH3%PA#FV*E/WE]1#G=5YH2C:4ZTPAP)V=!8@`$@X``-0``X@HQ@*I#-:
M`PC0<"8&,/:I,4(ZI#)0<R]F9:2RI$RJ(UYWI/,8I5,*!;;'9!S)H%GZ!%,"
MH_8%I=XEI5^J`A<A=4'6I69PHF=*`J5@II;%,,(9GV\*!(N!/%QZI65ZIYB&
M"/T09&/I.`S`#`\@DE[JISY@EWBYIR;P;;S&8XFJJ&/CF6IF+F\2``-G`6]"
M=Y@B`QE*J;+^\IHE&E[`]0\``&8>H)9TN%HVX*9GFIR&MBL8&7@GI9Q)$&O'
M=AV[VA%T(Z=^:@_-H&;`=3BP"5GNHC0L<`%52FT04693M2$CX`#N(ENL):HX
MD)[6<ZF(]":2\`G)&F\>D%]>UV\9L":7PF8+<*ZI*@)K`@$94`HV*I#`>J?T
MB6?`]1`3-"B*X'1)$`PB]W+[9@1-!0L#^P'&H(_-LP`%<*W8.@-35Z#<6@+"
M$Y*WD`CBN0(7<*[V-@!J*D`>ZP]4YYD3<W=94J]G"J&&QC@;0#4'(")_0*(=
MZ1@B8".'``H9X`'GLVM\`@]Y%Y4/&P/_H*S$BI\BD)X0P92*8`#^8CH><"<-
M:6`$B*&S5+88E#0"EB09"7@9G31__A=*6YM)87N#7-M*8QN"FC2V9VM*:_NU
M92NV9@M*9]NVP%2W=ON6:*M*<YNV<?M)>PNWK-2V?_NVJR2XGJ2V?7NXBIM)
MPC2OK'``"$-R3<LR-&L^R@H9.JNLS^2SR-%^Q+`3,$%"4A$668$481$30U&Z
MI#L74P&Z:H$6;H$6<'&ZJ/NZJDL4LTL6*+&[J3NZ(-&[I`N\0B&\,D&\+V&\
MJ[L!HJD*':`5R*N[KML6M\L3N=NZM8N[1I&\5T&[NVN[THN]9<&]2V&\L"N[
MVPN]H[M?AY0"&X`!.>M;\0%W+:<P_&#^*/NH6_TH4_\8J"T`JT/*<#/'IBO@
MD2+P(B8)#P7PK13D&(L1M=%V#GTW9S#PGZZJ#3;&*%RP:TXC*Q>L<!U<!6-"
MIJ6Z'1Z9$(RA1P-PK++*GS""`$V)'`$`6,X3M)E9I9P6?NY!P$7P)FLI(A[`
MPQ37EF^).P4PN27@OQK*9LW#:6.)`_NP!!3``!&P!12`C0S4`1&P`!.@:2@[
MI%-"P6N%PV"`Q`*:IB,\83_I-@6"#!D3JC3<'TMBQ$_Z:B3VQBZP&#(<P/-H
M`1#0H6W:Q1JZ)A+,Q'0,"SYSQEE`QM<I#8VJQ];Q$,/Z8W9L'E1)D$T\/9%,
M78`LG_9PK"S^R3#3(QPM-LDJ(*N6;+0O!P"B+,FD?`0#T`Q@/%B@K,H(MLFM
M:<+;2I!D8P20+%%VVLHD4'%T:668S`=N+*H1VYH\-3V)@P'.#)&_#,P?$"['
M:2Y]1YKO\I)E<,RBRJ'5/&($VZ-=5@`#4&9DH,A2:0!.-<R%?&72O+^.J\M\
M2E^V3)='&,NA)<9?@,Y;QV;SG&M-C*6MO'`V3)?Z[`7\G'!.>IP!W:?`'`OX
MW%II7,O`;,8175D-_:?HD<$UD-`KB[`F*Y\,8P$/<%AWX-&&AL>(G&7$3,LZ
M@$D#<`#$Q`'"1$(D<`%%N@!AF76M;)`.:LWV>,@YP&8&D,5AQ5C^/-H`P=`<
M_V``335),5?/"<>H&KK+R>/2."!,J@,/#1`^!S!!'J"41="0I<K-4TH^_'N=
M+9W)`WH`!RL\1D``?5.R'I`<!QPW1^S#TS0@>^T??+W&\`M.WN%1[A38]:`?
M@-W7FC)0\*'8\538COU1\$%/`0";?B.<'C50B#W8C8W8F^W7AJT@G\W8`^+9
MHEW!BDW:BRT>//40JWP#$L(&S"H)=NF?'\!F'/`/NL,/N(H""B#'L6JI#EJ8
MUE',R34][L*63W>YC*%5%N&YMSV$1$B%1#B$*3S=THW=5)C=0RB$VRW=W`W>
MWSV%X4W>XSW=Y"W>Z6W>ZTW=W;W=\.W^W>@MWMR-WMBMWMFMW>Q]W^==WO8M
MW_Z-W^9=WP0NX`*NWPC>W0;.WO0=W_,]A)W0`.]]X.\]X/%]X!:^WPK.X!F>
MX-7-X0ZNX1_>W@'>W^<=XO\]X@O>X1L^W^Z=X@->XB1NXNV-X@2.W4UETH8L
MRE9CPA'P!MF)&%C;W)7[=!WDOAF0Y$JNY`>@C4O^Y%`>Y5(^Y51>Y59^Y5B>
MY5J^Y5S>Y5[^Y6#.Y1BP`8E@D6%^YFB>YFJ^YFS>YFZ^Y&/.`+9]Q$*-="3'
M(8G1KKN6VQTRGDCI',"=I<(\H[.<.$KGS#N]`C8KM18C#X>0"A[`9C3F4PQT
MV'D]G-&!V0G^Q4W=D4Z>OM&@WNFE3=@<S<:#7:>+M^FJ?DV%;>GT0=@?5>H<
MM=JQ3NN/7IZ/;>JO?NJCSNN[OMJHCG.?+NK$SB#!3NJ+G>J:W>NK/NS&'NH(
MHI>+!]33PVMY?#&D:L)IP`#`@P#[.@!X"851_<;4/*0\90W@\BT#$)@ND)X)
M(`%\!)4<H*,/\`B5DPH(``$)U-N^+=5XYE5$6]7_K`,6<``]RCL:T'4'L*V$
M(0`2L6W^KF8&T+`SFM$4_;`UNM(`C<IP`R"H-L.B6J19*L#G'/%SS`\#S\X'
MW04H;6)==]'.1?)CT/(3MM!#2J8P#Z`F_V(0_:4R'Z.*^MQ+7/'^''],$%#2
M>F#6`AK'9VHR>@5MDWJG>?JE5@8,I'D<=J#TY^G33;_!(\`/*5QDFGRGC%Z2
M.3]<(T6P1<8/%DIH.Z]@E?RF@!/6C0Z?)_WV`=9R,$+U'']2IY`(;*VD?FK*
M<O]QTU/.$8#<B%KR9,])9(^?DK23[`[T?"\ADU[X^"$A+@,!$!`!/;.O47_6
MV7GVUT4V&M4?$H*4I)\"-']=4Y?+70\YXG(CCR0N*7\%K0]>Y?[X/\]U>!]>
M`"^J*Y_(OP]>$X^MO3_&Q6]=&2_\M]\XJ+W2N>]<]TRI%K\'6C]S_/C\`B\.
M^DX`\#4"&Z``B[:M%V#P-NVP,YH`J8/^_!^7>CF``)H*DJ+<LA[;,\V1"@?P
M``0`U>DP_2#PB2-9FB>:JBO;NB\<R_.;`='GT3O?^S\P*!S"=!!)KJ63Z2:`
MC`@#N'P8@^7A(!HL1@8$3,$ADLOF,SK-4P26ZC<\+I\#CR;-XP'90R8=GD'"
MB,>&#H%#$@6`A\93DD0;B8<.I<CD1\+8Y=)E3B6GIV5E:.@H)2>J:!+IYNJI
M:FJI*ZMIJBFMJ^UL9RON+6\M[*ZN[[!P<>SK!L!#4G*P+"APKO"S<S5V=':K
M+O&T]:]WMV4Q,OFWJK:S^'8Y-_:E':AB`("]_0#4C$?`!(?#`PPB.O0;88.#
M!0!_=-C0UT+^P1\Z$B=2K`AD@0`W%C=R[.BQ100D)>CI@?!@``!!,P@F"%"`
M``!$'`!82#(S`R02RP3JT`#P@8.@08$^(,``J-"A20$N12K4J=*D4)E*71KU
M:=.L5;=BY7KU*]6N8L%.+:MU;%BR9]5Z3>O6;%NG4`,0@`H7[5VV>,7*Y>OW
M:E_`?\/F?;O6<-S#A1<K;ISX,>&Q#PQ06"6B`H",23!KEL$A0`!]F#%XF&+S
MR80`)&8*%,&!`NS8L2M0.""!MNS<NG?S[NW[-_#@PH<3+V[\./+DRBE8.!"`
M`N[ETJ=3KV[].O;LR"\DF"#I@Z+.'R(`**#Q18>8JP8T^`#`NPC^&QL2+OP@
M18-E%6(^\N_OOPP_[?TW(($%FA&2"9@%<``""!A0CT@S#-#,)0,P\,$`B.B@
MB`<-/1+)=Y8MD<DUYPPB(HINC%(BBRNJF.*)+\H8(XTFVMABC3C.>*.+,/(X
MBX\ZYMCCCD+:J,,#`&P`I)%-$CED?B^2,R6*5$I9)997:O3DCT5RZ6207XH9
M)IE%9GGBB7:,=`^;!IP'`P,$&`1`959@H<4'1GF1P)LI[&<@H($"RD\7@AIZ
M**(FR$,./1EHL`$%`@``P0X<"#``!`X$`,8'EF9H``"M*7*``P2$%L88B:JZ
MJAP0.,(JK+%R9$2$(X1720(IY0?#!@O^$%#``VYLH,``"+0FP@4'#*"`0R[\
M*2NTT>[@@0`*2'LMMFDL:BL``]2G@*X&DI@MN>62($&HNYJ[+KLIT/K=K4DL
M``"GTU)Y;X@R/-LNOZQZ4&R_`0M,@IHD7$```FY(,,`!2Q:X[\`1#[BA:1);
M;&[!)?0)*,07>]Q1`7A^/'*L[VZ<:,<DJRR'(C6=O#+,`VXK:\HQVUR&`07<
MO#.@&=.<*L]!"W$!G4(;[9')T=9\--,N*-LTU!7Y'.O245M-@A3P7;VU&C.C
MB6C57#>M0P)7B'VV&5/#&C;:03-T@[IMR\W$!UZ+L$$#!Q!`JL/B`CUWU`N`
M"#CA-/C,4#W^;.;#\=^%&]T(I8Y+[L*[)H![P`4;5`"32@6..SG/.@@>$>BE
MI^"U!S!5ID,%!BSP<D=LFW[Q,AK.?CLY:H-J0`5]!RH[[@,[`$#CP9MNMQ/V
M!&!``U0P;OS*,PD(O>F5FW"!`C#=,SV!P%-O+I)*?G^[W8/@!.JKW1<_OL`$
M%<K^Y-8/L@#F-M7CLOKP6TQ>L_H[KCL`#J`)=*5O0-[S7[3X82T$.DY^24@(
M`%R"$@"\CT"?8^"Z=(`N*,`.@U<K7W/J$8`)=9!R)NB$QF9P0`^NZE_U8J'<
M'%@"#FR@$():(0P-13'GY7!NY3M/"5N0@68,@@(-D(!&.A`!!E#^((@CP&$/
M!16R*,:P;K5*@P<*((!!Y`HF!$B5!@1`%P"X"554Q%;+XG;&J*F-##IH```(
ML(0-=DH`%_J`WOZ@@0!PCP507..`#&``0+:MC62@P"$Z4X`NZ"`"JID)%8P@
M'E)<@VR:Z!*4O%0F,&FRDYG\Y)@\B<E1"DD:E3SE)U!)R5"2(R&K8R4I4ZG*
M5-)REK`TDBEC2:99\K*6K]"E*#D)2A/YLI>5A&4ERD>$SUR``I'@!PZB0#RB
M+4D'U'P!1`@IJP/H3)M<:^05S7``:SE2!^G!WS(@-;B=C&`#)2G)'DIR")/P
M@9[QK"<\\\F'=^+SGO[\IS[]"4][!A3^H/L\J#T%BE"#,G2@_/QG0@OZ4(5"
M5)\.K2A&$QK1?FX4H<-#0`3H>=&,$I2C`1TI2DW*T84RM*$J)>E$2TK1F<J4
MI@6MZ4AKBM.5QG2B/<UH2EFJT8[R(0('\(X3Z5:41D8"DJ?!"0!68QH=<$`"
M$[@J!:ZJU0D8(`)9M>I6PRK6L9*UK&8]*UK3JM:ULK6M;GTK7..J50E08``$
MR&I6Y:K7O885K'S]*V`#*]C![M6O9+5J!;J3!AM$(`,9T!0&.)">RL1'2<ZL
MA(><13IO(FH9.$@J9V.&(-#&`()L`L"%!$"A#]#'!OC94`"*YR)+GK)$3U)1
MCW:!2=Q6*9?^MQU$;GT+(]Y*2;@S(BZ:C`LE*WU-2S_2K2=TP`90]!:ZLIB2
M<)FKW3/A"+JSK:YM113<(S6WO-O-)9!^`5SPJO<8Z662<\^;7/;JUI!!(,0&
M--"!!P1`OQ]0@!9T$*<<!."S'UA`-YVUOM`6"')J9+#1E%F&G$B3`1EPE4B2
MU%@X4E;!$#84`P*PV0\S389N3(3(P".I29%@>!&,)C873&+^+"-8,[::A-]`
MB!%_H`,:(.T?;QP'.,I8R#NSKQQ(BX(@&SD-TGMPDV.&9+`5.<IT")_OK+RS
MI$&+R5HF`J&^?+0I'\K+8@Z"JUY[9IZ1V5!F7G,/%`CG+5L1RF7^KO*<S\"_
M/!\YG+"Z()]U#+!`PXS+/R.TCL&3+D3#K,TWQ#.C@;"W2*O,T%2#-*5Y@)E(
M9GIDCOX=ICL]@YR)^F,F9A6@2_V#A%3`SJI>UZ>?]^H@Z&W6'LLQE6T=YP\0
M36NZ#MBI5_5F6Y=-R;^6%:[O?.P=,';9$8NU@89=:NE.TMG\@O;#0FWMRAIX
MV^RR]-JTO>T0&]O;JL)V_LS-@MJINU_H-J"XG0U''K<;6^`&T,;Z9&QI=_K)
MY:ZWH-[-@W^S(-4`U\'PX@WP0]V;"!V0``,:T"P/4&`!$4AB!!:`Q!CPF]+N
M6WB[!*Z$#X1Q4RB)I@<04)XXIBH#H"G^0'GHG0*#`]Q560;YM1HN!`3(403#
M6]*>.R"`0G%3!QO@HZM%T'%&RYG@."^0R)4``"10M6B+3((C/[`,3F==$D7:
M3R]J*W99CKV4-#KNV=-.3+67_;=K?WO;A\OVW'IWOM0U!GF.1=WBPI>\V.U[
M>/]^]^S67?#:O87AJSMXOQ>^\81_/.,A'WC'1[[RDS=E,OT\!(I?T@8"*7`2
MB,8!T8=>?)I]>@Z6A?IR@1,.5"W`(&=2$]<\P9DZ6;36):#[W?->`@8X0N^#
M+_SA$[_XQC\^\I.O_.4SO_G.?[[R*3"\!DP`^M:_/O:SK_WM<[_[WO\^\BF`
M`*2B@1*N(L#^DIQ:=9P,3OU:KR?\]U``!X0T_O:_/_[SK__]\[___O\_``:@
M``[@`))1_1$@`B:@`BX@`S:@`SX@!$;@_AE5AZ%!!@Q`@2W!9"5!(ZB3&V36
M0RC<JR4$#ZT>N8R6!09``BS$$DS(9BB$A\#69OF2=&D"YAE3,>4@#NZ@#O8@
M#_Z@#P8A$&K##=)@V<&>+=56$-82+YT#$RZA$JJ2$T9A#SZA%*X#%?:2%3(A
M%LH2%'KA%;X"&%9A>!73V@6;$!P`(Y6``@R2@,D)-"5!&SK1TLV9#KB2"<*:
MY@G!3"```RS``C``L]@'!6%`DE"6JSQ`!C```+1:$-5AGM5:'I+^B\X!P08@
M0`%D(NP1@*A("NA9`G]EQAXNF0B*&M%4X"1B2]3Y@`=PP)L0`I"5HL20';#I
M``*832J2RRJR`!"=`<U9FPV,8BZV4)TYW:X%`21F2P=$5`EFD&-EP`:TA"P.
M(X'LHD<D([8<W3W4@^T`WM[ARWO1%Y/\73A^(SDTPFEU&S7*2B7FVL7<X*Y\
M1@3-XVJQ"SHJS]0EW3H&G#"Z(SO:G3&ZW&DQ``<XE@9HP#,Z"D(^XT$F9$,R
MI$$ZY$(:Y$0JI$1>Y$(^)$5")$-6Y'R<%MSL([2TH[(50:=PFAJ@5YQU0'YE
M``98``6$U`,(8@)P$P&($4CFI$[N)$_^]J1/_B10_B2,B22R]6-)QD!1B!L\
M.IT'L.0&N&0SR60#+$!-&@`!8.!.@H9=%0`"*,`"-$`>),X]+,!+6L`%G*59
MIN597H!9HB5;OJ5;6D!;NF5<PJ5=JN5<MF5:JB5=WN5;XB4&H$OB0(@^$N7$
MU)FT'%`'^(KR'(`C8N%*TA!44H`$1,`#3&4".,A5@H9.@H8`_,H!)$`@Z@%=
MF24T2A8*S9`(<281M<LRI&-A&J;,&*6;:9L-;"-J\6('2"8&-%-E7N8"*("#
MO`1GYJ1GVE5H*@`#.``$>%4%7("CH"93>H(K0D`!T!`8KI=N^>"]\,(98@DK
M;)<L*!'O-1;^L.4+O^S72PPBL$E`33Y`O"5;;<)`DHAE9M!&968*31Y`S@R`
M`(@19QXG:':E5])?:4*G!DA6!Y3;))R"=UX)"AR`(Q@C(75`5O4/ZUF"A&XC
M3YP0"MP=>GZHAYX`B'Y-B)X`N-S#`-R<NR!FM/QB"J6H3Z[8:=$%`RR1'G@5
M!4!G!BQ$(73`@L;FYGU'\O")P*`0A0J*,]T#`YR,OHTH>((HWYDH$)#'8-)+
MNVC0/,[C`KV`?`H*C)H`'-5H4!P%52Y`!3C(%VB1`!2`"-%HC>)DC5*0!?@*
M`7P!?RJ`<K8B<^9H9<+&&&0`CT)C#;DB):5`DMP#^JD+XA&2*0G^Y)9V8\GD
M`)#F`':F'$@&`'0VI6-Q:@9X:BMV:D%^ZJAVBF.9*JF*JJJF*A24ZJB&:JN>
MZE-"P:QJG:R>:JEVP(:RB8C!@#7&#J91S)6FV(=6*DM^JJ!:`$+H'DY\I04X
M0&9&0`)<)06`R]"AQ((D3@>HW):RR0%X`*C8ISUD`@30A5T)$B9:"P<D@(S>
M0\)T2I"^P)8(Z42L2('$`@V,J>)P`I!252'@%ZAV@*`"J5D2P@10`$O&9$'N
M04$Z0`,49`,\K`7HZ09<``(T3`5D`:00``%H`"(-@`9(P']N`'D`@`:4K`:X
MRA.H;,IVZVFYDSW`K)*XV#_80\W.K,W^CBD'Z"S/YJP]=``C*D30+F8$`>W/
M,J*(S4O2%JW2$JV(@<O3&J>V_2I''!#2LHD`5!.C`L$I_('`XH<&R.4'5$!(
M>`#$.<`RAJ8'Q(D!A)``3(";$H`%8*L"K!@"C%`FZJ0#6`!,#(`!9,%R/@`5
M/.4&&"K=D..14JF(\N(D/"605H`$Y)<#+(!+BBL^PJ0]8"Y-*,+F9F[R7,#G
M$M`%$!`&)$]@VL/IUEX`"$`&3$";9@`B%4`&-`<":,XX(82><@`&-(`#Z"Y8
M"FP$1(#`P@8AS,MI&4!O$L)9*N\%,*_S5FSSCE[TLJ7RDD;%"L1\-._UMB(&
M6*\%6.\%8&_^^#+"^&Y`]Q("!D"!!J0O]])J\G:`OM[#()G0EX(:#'#`PC8`
M!6"G24:)-9"HXJ[`)E1JK<)N35B`'42``K0'M_*JI&"*)Z(/,PC.-GYF:"+"
MZ)IF@BJ9DP9P#`R1_OX;A,99X_:HA49`#4UN]QK``)BE/50`!%4`9C0BT02`
M!60`G-J#:CE`X5X5_N[H;D+'@K)OA_QH!ABJ=]+K&8#K:;E,+_Q2O`Y"X0)I
MX5*"@DXQ2Z8*_@+I0=90C_88H1)NH>:`&!?D0N:`8X5O&J?O'T`*2+::K]+F
MHTVJ>,ZK"3V1RX8&2]J'68+'$7@`M#(1SRV2I!!`!TR0`P?`ZRC^0`(<T1Y0
MP'S<,,EM``N.'"]^C<K:@P'4!WC20(,BI"M"+C0Z@`)`)PM3@$!*@!1,W2JK
M\@A9@`:,4V3IP:>:Y8)6<;^V8O*TB34Q1TQ&0/5%`!5D0/#^IAX\``[L5QZ8
M1"#^X9(\0#,SP'YZAU%E9H,T"`%8"P9H(NQI8L>"ZP"$LUW9%>@A[6JN+J^*
M:P`40@[?`PY`+:\&T`?L<HWNIN7:@W<T,&Z24V<2`C[^<V6$:YO(`-5N1)B*
M:))NQ)2NP@4@LCTT@+T*,*7J4??"[F\*YP-T@)OJ9`*X6%W<)%DF`+``L@-4
M@`<<+!0XUABX(NQ84SQ7D+M,`BA3G"K^_X,"[*^R1&X]0,!K0@`Z1NZE[&]7
M*BM8?BIS]&CXCD%OPF166>8#5$:::J86U<,`D-P_LTE-P!QNUL.%#,^;@L;R
M?(#+K>[J7N550L$!?*8X;R(.1,"="A)<(T![9``")(!=W[5HCL'D2K,T!Z("
MU$0%_$0>`(6X,L`$A$0Q3T)E5B9B5R846(".Y@;V0D=TP(9)>T!TY&6@SN5:
M2C)"K"5;8L!!YD!%)J31X?`_=^@EUZ^L'4T&/$@$14Z^:%(14/%+QJ0%[%<6
MF(I8%@M69D9+E$=JI,0&F$J3<A,$>(!73H`'A!05Y$J-5A\&=,#D"C4!2("E
M,(,\]JX]1`#^!_BG!'3`%R!L`S``+#]R@EY`2,13F;Y.!TSK56)E/52&/D>0
MI%P((MDU(`($,/?8!52`",VC2.PFD"YH4V["@7\",?0'Q9P63%/B/(-DE[I`
M05L$-F9+ATPWU[*=O.[F[$+![DZEWFRFIM+S\M0#)TIH`EP`5Z>'<0)``QQR
M`&1T)BIB@T#`Q%+`R0+B'PHGSU4&'-WD:LHS/8#UI?CM@GKE<M(?,$.RK4YQ
M@YI0R0YT123#B/[6O+H!V\*U(&FM<]EKHY)C+RY>.F3Y#"`8EPM2L!:CTDRC
M\=`=X^)O#E!FIBS`Q1J```B$5BN/0[/)K_R*`(`!!H!U!(DE?F#^8#AS[-\>
M0&5(`%@&+VS()0=)9T*GG1M`0,1%;,02I`>+&AHFRD%[DYF`XWJM+TQ&@`/\
MH;B&S#AY93.0K(Y*.C0ZJ`@C]#C*)@JP=I*ID)M#&"VBP"'/8SWXVC$RWJR4
MZ+%]NC_:6BJXF)_CJTKB>G_H^AMP``0HP,5Q7*_/F00,E$E<DK0SG(MZQ%@_
MB"&;4;BG>T=0>QH(DM$%P!UYF+EQH;H?2H7WP-9AW2298PV&)S648SGR.W8)
M?.$E\3?R.\%GI\#O7<('O)@_/,'[78DVO,)#O)@W?,%W)\!?_,,'7G89?.(M
M?,=+?,>+_+^;/,.7?,@CKL?7".(=_+C^6P3KQ%;IL>B2R5R]Y_P;(,A'=-W=
MX%X'Z&5?)HL$6(`,&[W1'[W2)_W1_S<,*_W30SW21WW23ST,3WW5+[W62WW4
M=_W5RS#44_W39[W7F^78<WW6,WW:@SW3?SW;O_W9D[W5RR78N_W1JWW=TSW;
M5SW6H_W6BSW>[WW>PWW?`_[=YWW;ZSWAU[W;F_WB!_[APWW7![[5EWWB+[[@
M9[[E(W[3G[WA>_[G;[[DK[W<4WWBG[[DVWWC.[W?A[T,8P_Y*?1XJ,8(N)\&
M9+JF:WK$425>][[OWS6`+<OO#S_Q%[_Q'S_R)__PMZ'P*[_S/S_T1[_OMV$V
M2[_U7S_V3S_^"S-R]G>_]SL_]7/_]X\_^6M_\X-_`F"H1:0&Z8#@B>VN$L<*
M_%>Z@=RAI/*+_4=,_M/_O?(:(D`+"&"`]GD?%73FQZYKR<+M+-/FQ=2O:\<>
MWP*6A,`7C&?<]73(#TYF^M&@T^,LZ5ONB-<NU0J&51RUX;08`T?3RN_V[%V[
MX6E+XQLOM[%Z*A^O-J>&57$G)Z6SE/>'QD1W*`BI9`<H696&F:FYR=GI$P`!
MHU#@66KZ@9%SNLK:ZFIZ<?<Z2UOK.59FJ[M[:H)KQ!LLK%DX;'R<%HN\7`H!
M\'"Q`%#!').:6YW-^J3=[5H,["V>:4(Y?MYI08;.SO9!&=Z^"Q'^`"!`D6UR
M+<^O',^?[P,N@.W4$6P'[N`Y<PIY>5#AC5O#;OID3?0V\&(W>!JU&>SHT1#(
MD6GVD5SVY-_)6K[(J%Q9ZR-,8;Y$SG3XSN+-BR9W\O+GD]>OH+;*Z20:TR52
M6PR7RM.7XZ533\JFTBIF=1;'K*VP<FVU]>NXGF)A'2U[2RG:4C+7>C(HU>V%
M=6XIQJW[L&XI1'HY\>VKZ2]@3'D'&SZ,.+'BQ8P;.W[LZ2[DR91GA9,S4?(J
ME9J11KF,#6V\SIXO9>D+&K-3*8('LR:=]37%AK(3_[BM^';KRJ4:!/C].P$)
M7AD8+*!69\&""P`=`/^M8$.P:`LPN.O^X`"V,>?UH`_?19VY#PD*%%#0+DS!
M<P$+.`3#H-SZB@X0$C"PSD_];WOM@U50T$`&FG#0GSSZU2,``^[QDLIR:4!0
MG@()*-"!5=)(@"$$`P#`''HQ5`#```8`8%$#`!10P#.A!71AA@($@%\OFT1P
M(@$`1(!)!`%X&,P"`6`H`00OQKAB*0Z<F.(Z'1000`('`+``/P8,0$$$$C@G
M``DOQ44C`2GB6`*3"HR((X^TF'#``$`^$(```NIBXI0`6)!)`@"\V4Z:$T@P
M@7,#2*=+EU^V(``!!QA@P`$+EK:``&Q,B<1HG0P0Y0D`6'<!`!.P0".>XYC0
M*!M>$B;I)AS^`!#*!P\`L*`$"-ACYBZA^E```:0&QDD&`$C`@@27?N#<@A9,
M(T\!!Z31P0#'LE'J@"JJ"H!T-"[(0`KR)(JLB+>2PXD(^'RPP``\T!B`I^@@
MF@8'`B!P*S`JG?H`I]%^L$$`XGVE@*,S>,M"!^$.D(![-S`YP*:99*KE!P3<
MP0`I,0P0;SN-ZO8.ARQLD(```U`(0P8'M)EJ%A+LV,*/)2Q@`).QL@1N`$%4
M+![&`VQ<83E,$L"K.PX,D,8`=Q`0Y0H^%UD-MKA-<.?%"<S,0(4L6$`P!.&,
M[$(`.";`K@D4)-T.NKAM_2;&&B_@]#L$YYR%`[::H,&O-PC@:\+^['@M!8V`
M>CQS`R]00$``!-"9"0I.>V"U$_.:1I0"/+,1@"%>7H!!FA6*D(`=FAYA@HXO
M./F!`0JD@;4\L\9P:BCU(I#!!2B:D$$`!EC@S#IK-)Q&`;)H#<#*9X*K;PP=
MH$JO``=@@,'J%2M@^:8\'/#Y"@H<:T'"'8!2[+$O;+#K!QP$@/H%!!C`PM;(
MKZJ4%`W8&H/M'W10MF^ZSX)N&MCSNH'PQ!MZ`P#('\GK\@E\`B8/#"`"I_K.
MW,"7!EWA0P0+2)T`_F>I!5A`&ATRP_EJ%Z6114`!Q[&*"?*5"0)\SAE.FQZ.
MC/8!SF%B9S.XX`!D]P$&H.\<H.I=R>[^$"[2`0`?"9CA`P0`#`2P"P8'^-\*
MD/8^6HPN!@3(0;A6<*I-$<"('QA3"&UR039D;%'G0N`GXL4`(+*@;70:0%0^
M("1@J-`$"*`B!T8Q)Z(MPP1>BP'V0O'$BQ%KBJ+P(A-M`C$6/.\#NC+7.>('
MP,Y9#Q6_8D_Z*I6&0<)`B,"RQP%LI(`DHN.#-F0!I3YP@`)L(`,9V,#&/)`]
M$W!`.A:@0`7HQ$(8-(!G`H@8"[+(#A"R`0!DV!@'2+F!`N0`>";H@(`NX$HZ
M47*266,!$@&R1$_>X8&_+*4`&O`[:JA2`QZP0`4HP)P7RH"%*QB9`(B$#F,1
M!G@`JZ:N((#^O0IZ(`/=_"9S0L=,&'3@>0%01=?\^(&VA0)@H\R`!@20G1WJ
MDYO>I(!UQ"FT.T1@`!4JI!R9@<@69(^7!=65!.()@U5VDP+@3.&RV'BL/CF-
M1M]R2C2G%XH1O6@_#``I&PX@``&`+XTQ0)G"#`$J\&G2%#7$A$<_(```/(>7
MJ&QI"W"J4W`)E04&J!3NALJ*HC*.5TE=J@/:9JXE#8![G8-D#!W&@1%E!R!U
M'".QN@J<&XG`@&'*Z;$6X#"J-F\&6[M7%[,P+'QL"#A)A0!8L\`!`HSU?U5-
M@P`B@,H&7,`"OHJ`(<61T8!RZ%3KV94(`.4[Q3[PK&E@GB8<.97^64DA4P(J
M0"8YP($.<,`#V,.'*M^TA@H$0&"=^QSG5F``?Z)C8F;PE702Y`'8RC:Y"BTF
MD4SP0Q\((&0?>"8_0H4;A'W`C,F-[6QU5<%?^N"#0J5CE#@@HME>M&CES1P`
M*A2`["C7/>#5YW/1J*\?#`"/\BE!*@]HA2-5"*'=7:Y%;^L.*ZIR3MBK!P`>
M3-9_6H%JJ(3L?!G97PW@%@81$*,)`KF!SVSW<TO1:K\&,$0&+"Y,FW*D"1(`
M4.TI5'L!V)2.%E3;]0X#5"NF,8E'0;H"E'&OSE&""-XD@OZ>@&37M:$`?YS7
M#OSM`_$515YCL+4%G8I7#;@R6Y=UL<;^L>``8#:E=<1L@B)C(LDLT-5#14)&
M=M`1S(R4!0+*3(`SVS(!7J[N;L/'*NVQSP-)QNHJ,EJOB!F`BAD@`#>)^0'7
MNL/-;?[5QNR8O:DH0'\32D``"N`T#03@`*1$0`"D]8P,K,I@F&#`C?A&@"@H
ME@(3$$"?Q^%J"27`TP98@:X2D`$,&$``%?*5`S)`([7$X&.TCC`,K"N/7.O:
M=;X&`+"+1VQH/2`#1U*>J*A$`5N;0+&Z5@`";#NW`$3H50E80:8:B`$"Q!J-
MO,Q`[')AZ@F@8%F5S<`$M"6/CTG(W`!`@+NAE#IYF\!$$.#VY9*@V`K02+B5
MOJPX!+[K5Y'^V%(!NH"(%GZCXOPJ$_G>M[P8<`$)Z-30XX@`F<EL@`<80=B_
M(74,.FP/,&G"-P`X@'1,L(%769N+G_J`RU]N`*DE@TFC!BW.JZR)?3Z88\G(
M)$"._G*9+_TW"``M/=JD<TQP0.@($!@#7D[F`K`:'0]`^P'"_HZ^-6E13U]K
M)J2NO[)]/0!DXX<#D/YV3$`M.`OR`)MROHD-/*EQ6`@ZT<_1=K3#G6_0&9QS
M0N149&W:VF53^8/[;ACVD0,BFXA"V9#%<F.(_NY2*<Q25L\&TG-"]C`)!^U;
M</O1CUXU((&]#W*/">#OQ/>XW\OI?9?Z=O!^1<DONHZ??Q(A^.7^-#)R!_3G
M:`9N(6XJ32`,]46#C;B0Y@^\*;_YSX_^]*M__>QOO_O?#__XRW_^]*^__>^/
M__SK?__\[[___P^``2B``TB`!6B`!XB`":B`"\B`#>B`#]A^W=<&B7`(D6(%
M+F"!:X"!5Z"!4)"!U#>!&X@Y'LB!)!@(='"!+S."'9A](A:"(*B"+AB#9B""
MD(""+_@(']B"-#B#7)"#)5B#/+B#(K:"/5B!0&B$*3B$F(&#)BB#2^B$>/""
M1UB$5/B$B'"%5`B!6\B%7>@8??(`82B&#^``8RB&96B&::B&:\B&;>B&;QB&
M:&B&<@B'=<B&='B&=JB':XB'<;B'?SC^AGU(AFHHB(((B'!8B(>HB(O(B'N8
MB(U8AX\(B9,XB&1(5U:1`!'P323%B9WHB9\(BJ$HBJ-(BJ5HBJ>(BJFHBJO(
MBJWHBJ\(B[$HB[-(B[5HB[>(B[!H`0K@;5RA`(_GA<$HC#MA)67QBW/`&B4X
M@LO8@5@XA,SXC$0HC5!H@8F@C-/(A#V0C-#HC-W(C=5XA3L(!]T8A%H@A.&X
MC=,XCN`8!FB0CN)(@>R8C3<(A4H8C]<HC_GH!S[XC5VP!TC8C]P8D"QXCSL(
M`?V#+\`XC`O)D!IQD,:HD`TID1.Y26B$-KX8D12I?+J`'LU7&ARY%_3WD![I
M#<>HD1>A&23^V1C2-WV=H)(=86@/*18!8Q?,8I/.^'OC%1BZ41L;"1)_`91*
ML`$4X"D4HWW(4@'H]'U\T0'@=!E!250:P1=0B2Q..5Z[<1D68`&C89395Q2O
ML!NN(!AW$9:X,I()N1%QE#\5M`"AH#HL4`#XX0'J@SM*N6EQE3L-4"8TQ$9K
MQPQER2TZ`EH'H$V,Y%3D8FU1,"(/5G8S,"Q^A0(/)DJ98``51`'+@@'[\2=9
MT%<^`#!$XP$&`%JE9PO'5PHP!0.N4CL0Q`*960^;F4(/=B)$(@)KAP$;HE2`
M\R"R63C`8A,V:0J1\PH-0%VT0``&QV$C1YH+@)"D^2`7F14F^9?^'V`B(C$L
M>Y4`9.`]+$``XJ%B+R`->VD-$U!K#T!K510*I:*>+9D+'`!JP%)!%T$C\6("
M!8!NJQ(T]!(`"T0]`F2>?'-E#`<#(@!9&I!9VV69#J,^[ME,O<)+'5-P+ED"
M!/!S2[`D&1D9"3":IQDB*[5(;9-M5)4###IF"T!2""``O.4,^;D]9-,!U8(G
M"_<Z%.!JUB$!<`<##D`7[E(2?<89H$*?K0`,+U(V=J)DFY")TZ<`.6,",OD5
M--D+N$$:QN)%%M`F^)$`\6(!Z#,`S#$!Y4(K!C!$Y$```O)!XJF3UA=^/#I[
M!&":;*H+'7`E$;"AGJ`C`[`@]DE$A[+^`B['8:0@0')Y#T^%+2R``$K1`8.:
M!MV)9:20`2%Z4(5G=!'J7F.*E03P>#N`I[0P+#C:">C5FQ*P2!$P)8"36$[S
MJ!5B`-YV`&=T9P6P`@UP`"^``!MG`@QP1@=`%^Z09C;A+BM0/.'7+C$4I&-)
M5#8".%)F,:;Q8FC*@TD:`TZ*D=;7!$*"(O)F`#63@L!0/Q[W)A3@.1"4G4ZP
M.`.``=NS=JICI<<7!>8*`PO0`)MF$6S"J![@`"B``1[P*@-`#?2A(P*`'!U@
M:HWI`=CD!*'@:O\#`1WB:HI2`G8R`!:GIF_0:+Q))_.8!0_@)!&CIS3F<?CQ
M`'G%`0;CKK?^2F(98`"Z52&)!2@+MW'<F:!.\&<E(`&G%P&&`BAX-40CTT_Z
M$`$+\#F;"0%EXFD.:R()8)K:Z`ZO,F__*`?N>3Z9LT@($`$)(`NFM"!R2D<(
MR3?](@`?"Y>VI35B%`.X^JXYL"<LX`Q?ZP0Y12<;8`!\MP+A9C(78``T4@`D
MH`%A"`".QBF_D3,+$#%?ES,=8"<1X``=@`$1LP%Z$Z818[<#0"<5*YHE\``3
M544XP@U"PJ\R.V5-VIS1B:$Q<"2R:0])NPD2P#,%`";@VCHD,*X64*["]K*J
M\CGV$A@1"P.N%@$H0`VJFP&JJP(#@%P-@`#PL2,>H#$3-"]8\T;^[)(L[J&:
M)A(E",`K0F(!100L!H`!?&8+(^)@]C"ZT"5!8M2QX09*D*L_].29_24!"/0`
M"T`X=!)OF$`!7M:E,'"_Z_-I6ZD)$'``"[`I''``#0`^K=.[)C,LK[-='6"E
MTK$`BF)NE61UKB`"#^:7GSH`&J`F1G=2?P(!>84B%R`'!H`V!U4A%,`S2:<]
M&YPN69(&QE$"&S!E#A`EG3HQ&3`SUF$[P70'K7.0`:`!V),`%W``[/)KWO,_
M(`(!J\(<"T`&6Q,!JV(=/J(V[Z7#4BLJ#C!$#R!#=.):JF-$,Q,*20HW)W!.
MM69,GU9!TBJZ+(!,%2#'<RS'%&`!=A+^OC_22G/L2GS,6QP40Q"TOZWZ`0@0
M+]L9:2/"FE2%(P6@;`_37PJ@"DEJ`-]R`/C0FU\UH>ZQGR5@-<FRLGCJ`6[Z
M`:J)7A5R;I&&#XV60LS1`5K'"1I`4ATPE!1`RW:\-:9;#Q+``21%6[Y<RTZC
ML=O5R-^R`/_3=C%P>!#3KGCREJ#$*^JSOR4A+HL:LVBL5#65!1!`M3><B:3`
M#0H0"L,B,&5*`/B`7@+S)Z.<J=]$QR0E(+)L`4)W(J]4`GU,Q]^TLD`$`;;B
MI^_`,Q<PL[=I#XE+50BY/20`M-1Y+!Q\?(R:HTKU8,OB`#D@R1.*#PV0`U#3
MFK8BPYF[/17^\I:9*1T50`I6*TA1`L6%+`L7'0"3^V<%P!Q46P/W4+GG-F4T
M>9F>G#,)(`$?;;TLD`"A0-/1&KI6<8RC;+I+S=1-[=0MU<$JK#6D8*4II)U<
M:B\O'5*ZVV6Y:Z;H*4@X(@`3<`$HVTN@15LJ-[P+D@#5T:63=4X")+WLDLZ@
M=!XI.L-GE:_-\&#(UM?DXFI,'0$T<B?.4-@/!K+LHB&JS)TX4@%DNSX3\"I1
MX:ZM20K)(B!=/<TPX#U&4*\GD%?=)`VP^B"D1@H-\``2(+*-AB/@.@2U,F\>
M-UD"'4Z/MSU+70\YL"I-S3,7W-3,H2[L`R.N39W_LST76P+18&W^!PT#HB8=
M.+-DP3,X)5"RMS2C$X4C&LW8X$(&V@T!W(L!:GT`.3-;P8H*X(P^;REDX0,^
M@JLPXB'9]>,T!2`@0[U=17E.YL'.DMLO&A#!U)VS-B(?!!`!Q!/`A2R>;HS4
M6K8!J[0!#P[A&_"B$OU@;N+@#0[A#EYM<64=T\RZ*RV[GH0C#I!7(+(?(8H)
MU:T`8++B5*94]1`OFTI(!&!KQ";7+`"T(L#A[%S*=$U1=JTN1I!6]H`<?O'@
M/W#DM,4!O@UA"I7D3QYB+/``62,`V;LI]?+B'((;\N(>U2W9`I'E0'2;1J#:
M*7XO^\L7"C0#WZTP8Y=R@*H><>O8)S7^:GHZ+'%5V^2P2A?^X!7"/M+0'3U7
M,Q?.YZHD`-+1`#Z]+(L'XU[9.@)BPC%P`8Y2+W%%3VXB/X<>PV<T`:10T0J#
M'Y^NW:MRXDM2F.<-QZ1@WF]9IJD.+O'2ZN]`:C.$.D:G`*R,"6X"`0T@G%5N
M='Z#8NLCXSZ"`$$#5R12R,VIX)HVNK>$V^-K=-UI`=X3"M-\OX9,KIYD'=/S
M+0QPO%JIU82AXF"2I!3*/BH@0(!B`'H3O<H+*%EJM^LC>E(VURU<(9><+%'`
MO@&U-#RR>;))VJ8PS,!R*/B@<I-5/&1`AD.P/0)2W0V`0]^N6R0,(T^S3V:%
MH/H+SEDS;JG^TJ0G_=T>$`&D<+,"H@#Q0MSI3JH"`3ZQA>XRS@I8OM3QR0GJ
M(ATT/,'U,P$6`!^D0!YF4`#4$.E-"CZJB_`$0`8$WF;^-D,L8+8W8"N?7LDX
M?@?:;</:DUP(WF:_Y#`C[3#!NMXGT-ZP#M_`-D,&("`>TP#Y22C$<ZAW8"_<
M?@+'$KU"#0'3,UME^A"BY]-K#IT+[GW>-P$3$B'R&_AU<D:R"MI/=2-.@#X0
M3>+<R:J_Z4E?+<YA_=Z"1">8NCZ<C\)4UC]48DJJ=`#L0\K>;N^%+%C6T6C^
MXAZG;!GK\^\^)T=-"D')0BSE`0,A6UUC*M`5HKLM[/#H9@!DT$;^G$+C1WJH
M[_H_-#PXX<XI)+\N:`0^+0Y*<]X"F*J\&0#['5#Z/,Z>+X`!J#V&#:";:GIB
M"V(BG].UK;DCDSX?Y]0Y!B-`O-+6.0H^$S4Y!;!?6?#TVPL"G\-\"OD5DTA.
MQO=AR-<H;Q)MQ(L5W]7#>HG&:['X+!X?!+'$\`@RGXU@\_$8`)07]R.X>`H#
MBS=C.;PB:`^!8XLL'1_#%BE9WJ\?R-W3_0,&"@X2%AIV);@=+@9Z!)#Y601\
M4/3X40#`70R\#%R\0$UL!+CY/>C\>0Q@Z"G`E<`Y#&1`!'2P*1(\9&1A0`5$
M*`CX&21L(*"A1&#6=`B0'=PI$&`8U!C^+'0TR#`.:EAD^!V:)N@]`)`);/EA
MD*(D6$@$D*@6(P009;C[.>AH!!RH``$``7%<+`"`@,$!`%8?&!"@4`F('@@]
M,@`@\J#'Q@SG2%1(QL8*`QD'$&Q0L$9=MY:!.%1YH0&`C`3TK@388J"`Q`+)
M$`Q(D""`#"CK/DCJ@&*`A`D"`$@!-2.``@0(M,P@@3`"`ULB5CK00("$O@CR
M.&0`PB/(BQ\?*F0:^(F!'$P1SK%"4`!#`@!6'@)0^D=`A26!O5P89:%"@`*W
M!OR]@712!`$8Y%FQ:9"/R\Z>/RM0M,@/Z44;LG'I$#I#DRL*"K-^T4"#'@D/
M+K3^D&&!02[^#/Y^B%`X>&$/"P*,N<)`,`4!ZA8<8/,@P!>9!@`JPC3@P:M[
M>SYUN'K`308"`@A$_:R>`@0N'!*$6R#:@P(I&K(`..&AP<D#[9'FMIL?O``0
M``0(',&%'TX!,,!PK@4`P'A_5"`'?9]4^$%X`"@@2089R*&<4J=YP$$6!ORE
M@%>=E=8;(1TLQ\4#2C#P"1<.W,'!50`D(!@$_<7(`6HO=+"`%$5&R$`#%+U`
MP4G(U$%!'@-5YP,`=VP2`&\OR!/`'1HT`>8'8NH6XD#`I%''=&A><4`F*'+I
M`B`,2#$!$1[0^<$Y!%A0@!PQ[D'&#'-1-YP$5U;4AWJ+,AI(:(W^0AHI(QZX
MJ"!IE!)P2V^4IK*I8%UX6NEGHDIJZ:*<<F!C*I^"2BHAG.IA"*R@L%IJI)RZ
M*BMI@G8SZQ7B>%"KKZ.1.BL84SCV`@06]GKI.+W=P@5GME+;S:/5#B)JI=I"
MFFLJ`X@&B+>-8-MHL:^",BZHU+JJ[KKE3NH9KKT*4IJM[C)B@!S\_7H`K_6>
M6LBT\!+\1R(%(XQM!YDFW+##DN+[L,034SP.#!$&\,D&/%;L!V<15[S(M2&3
M7(@'X92<LLHKL]PRQ1U<()@'QX8\L,N>C7RSSCOSW+///]\,,K4V`UU(SD4C
MG;322S/==,=[*.IT%T=+7;755V.=-=.=1%>M@!64@AVVV&.37;;99Z.=MMIK
ML]VVVV_#';?<<]-=M]UWXYVWWGOS73?4L5J=@#U6)6"5X84;3KCBAR>^...-
M(WYXY`A,[GCCE$/^N.:.5][YY99SGKGHDU>.^>>F:^YYXJJOGGGIK(..NNRS
MPPZZ4*)O;CODM9M>>^FQ1\X[XJ1?_KONQ[=..^[(,S][\Y3[?KKRK2<041<A
#```[
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g101481bci001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g101481bci001.gif
M1TE&.#EAP``@`/?V``````$!`0("`@,#`P0$!`4%!08&!@<'!P@("`D)"0H*
M"@L+"PP,#`T-#0X.#@\/#Q`0$!$1$1(2$A,3$Q04%!45%186%A<7%Q@8&!D9
M&1H:&AL;&QP<'!T='1X>'A\?'R`@("$A(2(B(B,C(R0D)"4E)28F)B<G)R@H
M*"DI*2HJ*BLK*RPL+"TM+2XN+B\O+S`P,#$Q,3(R,C0T-#4U-38V-C<W-S@X
M.#DY.3HZ.CL[.ST]/3X^/C\_/T!`0$%!04)"0D-#0T1$1$5%149&1D='1TA(
M2$E)24I*2DM+2TQ,3$U-34Y.3D]/3U!04%%145)24E-34U145%5555965E=7
M5UA86%E965I:6EM;6UU=75Y>7E]?7V!@8&%A86)B8F-C8V1D9&5E969F9F=G
M9VAH:&EI:6IJ:FMK:VQL;&UM;6YN;F]O;W!P<'%Q<7)R<G-S<W1T='5U=79V
M=G=W=WAX>'EY>7IZ>GM[>WQ\?'U]?7Y^?G]_?X"`@(&!@8*"@H.#@X2$A(6%
MA8:&AH>'AXB(B(F)B8J*BHN+BXR,C(V-C8Z.CH^/CY"0D)&1D9*2DI.3DY24
ME)65E9>7EYB8F)F9F9J:FIN;FYR<G)V=G9^?GZ"@H*&AH:*BHJ.CHZ2DI*6E
MI::FIJ>GIZBHJ*FIJ:JJJJNKJZRLK*VMK:ZNKJ^OK["PL+&QL;*RLK2TM+6U
MM;:VMK>WM[BXN+FYN;JZNKN[N[R\O+V]O;Z^OK^_O\#`P,'!P<+"PL/#P\3$
MQ,7%Q<;&QL?'Q\G)R<K*RLO+R\S,S,W-S<[.SL_/S]#0T-'1T=+2TM/3T]75
MU=;6UM?7U]C8V-G9V=K:VMO;V]S<W-W=W=[>WM_?W^#@X.'AX>+BXN/CX^3D
MY.7EY>;FYN?GY^CHZ.GIZ>OKZ^SL[.WM[>[N[N_O[_#P\/'Q\?+R\O/S\_3T
M]/7U]?;V]O?W]_CX^/GY^?KZ^OO[^_S\_/W]_?[^_O___P``````````````
M`````````````````````"'Y!```````(?XU($EM86=E(&=E;F5R871E9"!B
M>2!!1E!,($=H;W-T<V-R:7!T("AD979I8V4]<&YM<F%W*0H`+`````#``"``
M``C^`.T)'$BPH,&#"!,J7,BPH<.'$"-*G$AQ8#<WSBIJW,BQH\>#Q]RXT?91
MX2D"GDJJ7(FPF[9V)<WEFG@+!```>E@6=.<'P2F=0#VVJW8*$8H,;FAU<]>Q
MTX9C$-N1,@$!`(*4'F7")-BN#(1(6X.*G1B-2X4-3PY5PI(!1;*.I()D?(B(
MP(U(!,HP]>C&9\%<$,B$'4NXH3E$(!Z4>3L0E@LV'=V9>W@80I1H<S(P[ACH
MP8-;!%NY^#*9X\6YA$_9*1TQ&18$2&`=/(6B6F&!YKX`N!'-'(PR'V]5/32P
MW:$'-KIY;(6`U&WFCB3"RF"BU6""VD`X+^QN#@(WW^S^G3(!U>,A`!FB#:Q$
MP,2PC]]@L1[;;@<6B5@(=%*H;0-6PK`\()@]YB#A1DE8`"#$5K!4%=UM+$41
M1435;)`!20E%L\%/A'5C@Q"EN0&";1YUXT(%*;6#B0D5S#$?A`]U$@4M"441
MQ(L+G8<`&]<1U,F(A+7S!02RV8/)!H%\E!L!F-C3#1D(V``,C!.U`@$!E=1X
M84/N5#-'51D\@>-`4=Q'6"09-/E-(!MD^9$C`"!A3C4[`/"%<E1&5$D&!,S1
M(YE;+F3.'!L\`,`.T?PI$"80[#?6+1E4XHXG*$#0Y$?'F-`<+#8$-F:>"E4#
M`@&'['50.T&X\&EC0MA%2@7^9B*$R0,NX!F4.5@P84XE$"!!BZD=)8C`#@AD
M<`NP!"7C22>GK'I;7Y$@6Y`V&4R8T*"T=N)2M0G=4L$#CMYJ!P2>E('`G=60
MTFQ'PMUTTPYCWL*6NP,>9`XMBG[4R0-<Y"O0,0_$:I`V"091'K4"$^0)GX%(
MNY(>`!!0`0)S#/-$!C=]X:]A7!#@AQL8(P!609D2``,63Q"P`88&,=H*0<>4
M%Y%D(%$E<T*>`#!'2PG>@!K"!SD%0!DPN=.-LQHY8\)-#]@!3!#H"6'"RAO!
MN:`]R6`2!01$#]2)"4&T8DX[B"```H:TH&8/(G%J8PXP9M4J43=<;#?0,#`\
MX"?^0SG_1U`U-^AMJSW46CO0H`BT6!HF(+@PI4"=Z(%T0W3?9$(GL,`@A">V
M'<ER0=4X4D9XU\(`P(,"M0.EFZ=`0)H]W_2ELT">G$L0VP"`L`.8B(1UM$-^
M"`P,""([U`D$-T..`@RP(*M-!88[J9N4ZQF*!8F5/`""K>;8X3=N<SQXS"E;
M=>.("P2X,$<TPV1`FCFM>/+$#9.UH\U2BVZPVZKF]/4Z01ZJ@#.<`8(;'*T5
M-C";B^PQ#!00(!(6@4$%8$```-@`$S)S!RE`P".+N*T@YHA$!>QP-_1UC2&X
MTA571(B$S1"$%A2SA]$Z@0(!X:D:;GA`!@Y1/UX!`!'^%B'#T`CR-B0`@`G=
MV),)DM&-7-R`3RA0CSEL`()A`,,&[N("+=P0A`PX3AN!J`J1KJ6;_Q6D%020
MT`,\X8D;0*!-RG$')BH`@$-L15X;JLL72">09'"A*FQPA[+88`(3T"AU"-R`
M&R9CCD-DX`%^*-\I\&6O+SS@90290P6BA9#SL($4;-@`!&X`#)@<(Q`V`<%,
MG$0&`B!E,N[@5)S"8XY3S*%23,L``@`P01L$P1'58-,MNM$^5U;E)M3!Y4U`
M4`$39"!-"CE/;1#2#B&XBT]"@`6>_+C+&\$N>Q7(!2PV8,9;E`%C[XH".@$0
M"`8Q(4J/LT<GK`)!@72C3@3^X-!`8FG$>OTK`TDBHC:T$8VON0L%7%A7-S)S
MDPWDHAU;=`$`7/">H<S!4'WJ!!GJ!"O3W>0L&_AE-4AW3PAD8`,F>`(6RC2'
M4U3C?G9P5P78<`L3H.X@)LJG0A)TS8RXXQLUB1@`GJ`-4J```7VR!Q8JH!X"
MG2)D0D"!NR`@!&9FI!NDP-@32&2/=C#A4*5QQWE,%D^GTM&`]@`&B6#H!Y=T
M(QJG8,))*U!!7GZ!J]WX*@&J@H1JZ&&7`!CCVNB(`JFZ"P'95*I5N)",@?8H
M&F6(0B`&QQ5K!O9E_0D70CHQLH0(:P,5M`\30,#7-KJR@B[H!$S,I0=,?,&!
M$&#^`BS:$0TV>N(8[H#3#IZP`02@8#78\2(MM'$,3""!``@X!.F^H0T$(I<+
MZOF&YI33CB@@P$(G168&@O`$!)B@K%<$@`DB00M=9F""<WB"#9Q!BS(\``)<
M<$9MYW`(3U#2'J2HV\88`D/8_,I))MA!*2NBC1NPLQJ=^`(33,"$*+AA7<?X
M@H-)8:MNV,$%7G3P,11E#D<\H4R(X*-%-+6!#4SLF0]HL(0P_``4?,$ZN-F!
M3IUTBDIPP0UL/$4TM.$.:AT(-VXX"QM\FHM.W'8RSOC"#L!VB`T3IAIV@+'7
M,!R$)L/$'-&03T-PZ(CYB-@P'^2(.VYA9#;>@J"D<(-MA*+PA4I0V"!8Y:I"
M:%&!0^8&*=5PV#X="RH0MK<"$`A"%$ZT@R_W^=`+"002PG(,%R)Z9LDXQ)HQ
M\NA**Z0;0="LI3?-:9V0(3V=#K6H/3*\18_ZU*A^2#O.%P30I/K5L#9(.SH!
)C,G%>B$!`0`[
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
